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ABSTRACT
The Neurocognitive Impairment Associated with 
Comorbid Schizophrenia and PTSD
by
Lisa Duke, M.A.
Dr. Daniel Allen, Examination Committee Chair 
Associate Professor o f Psychology 
University of Nevada, Las Vegas
Individuals with severe mental illness report a higher incidence of trauma and 
PTSD than the general population. A trauma history in individuals with schizophrenia 
has been associated with more severe psychiatric symptoms including positive 
symptoms, depression, suicidality, anxiety, somatization and dissociation (Beck & van 
der Kolk, 1987; Craine, Henson, Colliver & MacLean, 1988; Ross, Anderson & Clark, 
1994; Darves-Bomoz, & Gaillard, 1995; Holowka, King, Saheb, Pukall & Brunett, 2003; 
Strauss et al., 2006).
The current study is among the first to examine the influence of comorbid 
schizophrenia and PTSD by performing comprehensive diagnostic, symptom and 
neurocognitive evaluations on four groups: normal controls (n = 26), a PTSD group {n = 
21), a schizophrenia group {n = 26), and a group of individuals with schizophrenia and 
PTSD (« = 21).
Participants were administered the Structured Clinical Interview for DSM-IV-TR 
Diagnosis (SCID). Those who met diagnostic criteria were administered a battery of tests
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designed to assess psychiatric symptoms (Schedule for the Assessment of Negative 
Symptoms, Schedule for the Assessment of Positive Symptoms, Brief Psychiatric Rating 
Scale, the Calgary Depression Rating Scale, and the Post-traumatic Stress Disorder 
Checklist-Civilian) and an extensive battery o f neuropsychological tests in order to assess 
all major neurocognitive domains. It was hypothesized that the combined effects of 
schizophrenia and PTSD would produce greater neurocognitive impairment than either 
disorder when it occurred alone.
Results o f neurocognitive tests indicated that the schizophrenia groups performed 
significantly worse than the Control and PTSD groups in all neurocognitive domains. No 
significant differences were present between the PTSD and Control group. While the 
differences were not significant between the comorbid group (SZP) and the schizophrenia 
only group (SZ), there were some domains in which the mean performance of the SZP 
group was different than the means of the SZ group. The SZP group performed 
approximately one standard deviation poorer than the SZ group on the Attention Domain. 
Conversely, the SZP group scored approximately one-half of a standard deviation better 
than the SZ group on the Executive Domain and the Visual Learning/Memory Domain. 
Results of this study do not support the idea that the presence of comorbid PTSD results 
in increased cognitive impairment in schizophrenia, more than what might be expected in 
schizophrenia alone. In fact, the presence of PTSD in individuals with schizophrenia 
may be associated with slightly better performance in many neurocognitive domains. 
Results of this study do, however, suggest some areas of neurocognitive function to 
further investigate, including Attention, Executive Function, and Visual Memory. In 
conclusion, while the presence of PTSD in individuals with schizophrenia is associated
IV
with a different pattern of psychiatric symptoms, PTSD may not significantly impact 
neurocognitive function in a consistent manner, if  at all.
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CHAPTER 1
INTRODUCTION 
Traumatic events are no longer considered “outside the realm of normal 
experience” as once described in the DSM-III (APA, 1980). The definition o f what 
constitutes a traumatic event has subsequently been revised and includes two components 
in the DSM-IV p. 424 (APA, 1994). The person must have been exposed to a 
“catastrophic event involving actual or threatened death or injury, or a threat to the 
physical integrity of him/herself or others and the person's response was marked by 
intense fear, helplessness, or horror”. This change was made in response to 
epidemiological studies indicating that a large number of people have survived a 
traumatic event. Current estimates suggest that more than half o f the people in the United 
States are exposed to a traumatic event in their lifetime and a substantial portion of these 
individuals go on to develop post-traumatic stress disorder (Kessler et al., 1995). 
Prevalence rates may be substantially higher around the world than in the United States. 
For example, the rates of traumatic events and corresponding diagnoses of post-traumatic 
stress disorder (PTSD) in countries that have recently undergone political duress and civil 
disobedience ranges from the upper teens to almost 40 percent (de Jong et al., 2001). 
Additionally, considering that many traumatic events are not reported, the actual numbers 
may be much higher than those currently reported.
These statistics become especially alarming when one considers populations with 
severe mental illness, such as schizophrenia. Individuals with severe mental illnesses are 
at a greater risk for experiencing trauma, although they may be less likely than other 
people to report that they have been exposed to a traumatic event. Resnick, Bond and 
Mueser (2003) found that 38% of those with schizophrenia who had been traumatized 
had not discussed it with a counselor, 36% had never told a friend or family member, and 
28% had told no one other than the researchers in their study. The presence o f recent 
trauma (within the last year) was reported by 79% of mentally ill women (Cascardi, 
Mueser, DeGirolomo, & Murrin, 1996). Some of these individuals who are exposed to a 
traumatic event will later develop PTSD, and so the increased prevalence of traumatic 
events associated with schizophrenia coincides with a higher prevalence of PTSD in these 
individuals. The incidence of PTSD in individuals with severe mental illnesses is 
between 29% and 43% compared to an 8% prevalence rate in the general population 
(Mueser, Salyers, Rosenberg, Ford, Fox, & Carty, 2001).
There is also evidence to suggest that trauma history in people with schizophrenia 
is associated with deleterious effects including increased symptoms and poorer functional 
and treatment outcomes. In those without schizophrenia, Ross, Anderson and Clark 
(1994) found more positive symptoms of schizophrenia in those with a history of 
childhood abuse. Similarly, in individuals with schizophrenia, a history of physical or 
sexual abuse is related to more severe psychiatric symptoms including positive 
symptoms, depression, suicidality, anxiety, somatization and dissociation (Beck & van 
der Kolk, 1987; Craine et al., 1988; Holowka, King, Saheb, Pukall, & Brunet, 2003; 
Strauss et al., 2006). Trauma history has also been associated with hostile behavior.
substance abuse, and homelessness in those with sehizophrenia (Goodman, Rosenberg, 
Mueser & Drake, 1997; Mueser, Goodman, Trumbetta, Rosenberg, Osher, Vidaver, 
Aueiello, & Foy, 1998; Lysaker, Meyers, Fvans, & Marks: 2001). Furthermore, it has 
been noted that psychiatric patients who have a history of abuse as children are more 
likely to attempt suicide, have more symptoms, receive more medication, have longer 
hospitalizations, and have an earlier first admission for psychiatric treatment (Mueser et 
al., 2002; Read & Ross, 2003).
To date, there have been few studies that have examined schizophrenia and PTSD 
comorbidity, despite a large body of evidence suggesting that both schizophrenia and 
PTSD are associated with underlying neurobiological dysfunction. The only study 
examining neurological function associated with a trauma history in individuals with 
schizophrenia found deficits in working memory and information processing (Lysaker, 
Meyer, Fvans, & Marks, 2001). These results suggest that the presence o f trauma may be 
associated with increased neurocognitive impairment, which would be expected to 
become more severe with diagnosis of PTSD. The underlying neurobiological disruption 
and the resultant deficiencies in neurocognitive function, or how these neurocognitive 
deficits contribute to the uniformly poor outcomes experienced by those with 
schizophrenia and comorbid PTSD is still unknown. This study utilized a four-group 
design and administered an extensive psychiatric and neuropsychological battery. 
Neurocognitive function assessment included Working Memory, Fxplicit Memory, 
Attention, Fxecutive Function, Fmotional Function and Motor Function, representing the 
neurological areas implicated in both schizophrenia and PTSD.
Results o f the current study indicated that the presence of PTSD was associated 
with increased levels of positive symptoms as measured by the SAPS, decreased negative 
symptoms as measured by the SANS, increased levels of depression, overall psychiatric 
distress, and PTSD symptoms. This study hypothesized that the neurocognitive function 
associated with comorbid schizophrenia and PTSD would support a synergistic model 
where the impairment would be more than the sum of the deficits associated with each 
disorder alone, wherein those neurobiological systems that are compromised in 
schizophrenia are particularly susceptible to the neurotoxic cascade o f stress hormones 
associated with PTSD, however this was not supported by the current study. The 
presence of PTSD may not have contributed to increased neurocognitive impairment 
because of the severity o f the deficits associated with schizophrenia alone, meaning that 
the neuorocognitive deficits associated with schizophrenia are so severe that the impact 
o f stress resulting from trauma may not further impact function. In the particular 
neurocognitive domains, the Attention Domain may represent an interaction effect in that 
it was the only domain where the comorbid group exhibited slightly poorer performance. 
Similarly, in comparing the PTSD and Control group, there were no significant 
differences. Although not significant, the Visual Memory Domain appears to be 
influenced by PTSD and should be investigated further in PTSD and comorbid 
schizophrenia PTSD and schizophrenia.
The results of this study have a number of important implications. First, they can 
contribute to improved treatments and functional outcomes in individuals with comorbid 
schizophrenia and PTSD. Results of the study suggest that clinicians working with 
individuals with schizophrenia should evaluate their clients for a history of traumatic
events to better treat psychiatric symptoms resulting from PTSD. Second, results of this 
study suggest that the presence o f PTSD does not contribute to additional neurocognitive 
deficits. However, there was an interaction effect for the Attention Domain indicating 
that the presence of comorbid PTSD may selectively impair performance on this domain. 
The results also provide a first step in understanding the complex neurobiological 
dysfunction present in this comorbid group, and thus provide direction for future studies 
using different experimental methodologies (e.g., neuroimaging).
CHAPTER 2
LITERATURE REVIEW 
For individuals with schizophrenia and other severe mental illnesses the rates of 
exposure to traumatic events range from 87% to 97% (Jacobsen, 1989; Lipschizt et al., 
1996; Hutchings & Dutton, 1993; Goodman, Rosenberg, Mueser & Drake, 1997; 
Goodman et al., 1995). Trauma history in individuals with schizophrenia is associated 
with a worsening o f symptoms, higher rates of substance abuse, greater risk of 
homelessness, and increased hospitalization (Goodman et al., 2001). Given the high 
prevalence o f trauma in those with schizophrenia, combined with the increased 
symptoms, it is somewhat surprising that few studies have attempted to characterize the 
emotional, interpersonal, social and cognitive function in those individuals with comorbid 
schizophrenia and post-traumatic stress disorder (PTSD). To address this important 
deficiency in the research literature, the current study will investigate cognitive function 
in individuals with comorbid PTSD and schizophrenia. In the following sections, 
literature is reviewed that is relevant to schizophrenia and PTSD, with an emphasis on 
cognitive and neurological abnormalities, in order to provide a background for forming 
hypotheses regarding the neurocognitive dysfunction resulting from comorbid 
schizophrenia and PTSD. Ultimately, results of this study can inform mental health 
professionals working with individuals with schizophrenia of the importance of detection 
and treatment o f trauma with the hopes o f minimizing the sequelae o f trauma.
Schizophrenia
Schizophrenia is one of the most severe and chronic mental illnesses and the 
presentation and prevalence of the disorder is consistent throughout the world. 
Schizophrenia has been documented as early as two millenniums before Christ, in Egypt, 
and is present across the world. The lifetime prevalence rate of schizophrenia ranges 
from 1.4 - 4.6 per 1000 (Jablensky, 2003). Another review of the lifetime prevalence of 
schizophrenia found a mean rate o f 4% (Saha, Chant, Welham, and McGrath, 2005). 
These prevalence rates are much higher than the .5% and 1% prevalence documented in 
the DSM-IV (APA, 1994) or the National Institute of Mental Health (NIMH). However, 
based on the more commonly accepted prevalence rate of 1.1%, 2.2 million Americans 
would be affected by schizophrenia (Regier, Narrow, Rae et al., 1993).
Schizophrenia is a lifetime disorder with age of onset in the late teens or early 
20’s. Because of the severity and pervasiveness of the deficits associated with 
schizophrenia, many individuals are unable to maintain employment or live 
independently. Schizophrenia is one of the top ten causes o f disability in the United 
States and costs approximately $65 billion a year (Wyatt, 1996). Without support 
systems and the ability to live independently, many people with schizophrenia end up 
homeless. In fact, individuals with schizophrenia make up one-third of the homeless 
population. Individuals with schizophrenia have a shorter life span than the general 
public because of a 10% incidence of suicide, comorbid substance use disorders (in 
particular nicotine dependence), poor nutrition, and inadequate living conditions. These 
statistics become especially troubling considering that many of these adverse 
consequences could be mitigated with proper treatment. The World Health Organization
reported that 80% of individuals with schizophrenia could be free of relapses each year 
with proper treatment (World Health Organization, 2003).
Because schizophrenia is a brain disorder, people with schizophrenia exhibit 
problems in a broad range of cognitive and emotional functions. The most characteristic 
symptoms include hallucinations and delusions. Individuals with schizophrenia also 
exhibit disorganized speech, disorganized behavior, flattening o f affect, and loss of the 
ability to experience pleasure (anhedonia). Individuals with schizophrenia may also 
show impoverishment of mental abilities including impairments in language, memory, 
attention, abstraction, motor function and emotional processing. Associated 
neurobiological abnormalities include abnormal brain activity documented in EEG and 
imaging scans of the brain, eye tracking impairment, ventricular enlargement, brain 
asymmetry, decreased temporal lobe and hippocampal size, increased size of the basal 
ganglia, decreased brain size and abnormal blood flow in the prefrontal cortex (Liddle & 
Pantelis, 2003). These neurocognitive deficits and neurobiological abnormalities have 
been found in individuals who are experiencing their first episode of schizophrenia and 
have never been treated, as well as, in patients with a chronic disease course. Similar 
deficits that are o f a less severe nature have also been identified in unaffected first-degree 
relatives of those with schizophrenia. A more in depth discussion of these neurocognitive 
findings and their corresponding neurophysiological abnormalities will be provided later. 
Neurocognitive deficits are core features of schizophrenia, and are not simply the result 
of other factors commonly associated with the disorder, such as medication effects, 
symptom severity, length of institutionalization, limited educational opportunities, etc.
Etiology
The search for causative factors in the development o f schizophrenia has focused on 
both environmental and genetic influences. The diathesis stress model is the most widely 
accepted model o f schizophrenia. In this model, genetic vulnerability combined with 
environmental influences results in abnormal brain development and expression of 
schizophrenia. Investigation of environmental influences has predominantly been limited 
to perinatal factors such as birth complications, exposure to influenza in utero, etc. More 
recently, environmental influences during early childhood have been examined with an 
emergence o f research documenting that early life stressors also alter brain development. 
Thus, it is clear that both genetic and environmental factors contribute to the onset of 
schizophrenia and the most consistent findings are reviewed in the following sections.
Family, twin and adoption studies provide the most conclusive evidence for a 
genetic component to schizophrenia. Most convincing are the differences in concordance 
rates for schizophrenia between monozygotic twins (46%) and dizygotic twins (14%) 
(Riley, Asherson, & McGuffin, 2003). Additionally, relatives of individuals with 
schizophrenia are much more likely to develop schizophrenia than the general population. 
For example, a sibling o f an individual with schizophrenia has a 10.1% lifetime 
expectancy rate for the development of schizophrenia (Riley, Asherson, & McGuffin, 
2003) in comparison to 1.1% for the general population. Additional support for the 
genetic influence in schizophrenia is provided by studies reporting that many unaffected 
first-degree relatives o f individuals with schizophrenia will exhibit similar symptoms and 
neurocognitive deficits as those observed in schizophrenia, but to a lesser degree 
(Sponheim, Steele, & McGuire, 2004; Conklin, Curtis, Calkins, & lacono, 2005; Chen et
al., 1998). Subsequently there is strong support from twin and family studies to implicate 
a genetic mechanism involved in the expression of schizophrenia.
Despite the strong evidence for the genetic influence provided by twin and family 
studies, there is not a single gene identified in schizophrenia. Thus far, genetic studies 
have documented abnormalities in many different genes. This line of research is yielding 
a remarkable number of genetic influences or separate gene mutations. Specifically, 
research has documented a specific mutation in the WKLI gene that is responsible for 
catatonic schizophrenia in one family (Lesch, 2001). Another study suggested that the 
HOP A gene may also play a role in the development of schizophrenia consisting 
primarily of positive symptoms. This gene is x-linked and so 1 in 30 men with this gene 
will have schizophrenia (Philibert, Andreasen, & Woods, 2004). Other research has 
documented abnormalities in the Dysbindin (Schwab et al., 2003), Neuregulin 
(Stefansson et al., 2002), COMT (Egan et al., 2001), and G72 genes (Lin et al., 1995). A 
particularly relevant genetic finding is the glutamate mutation on the SNP4 section of the 
GRM3 gene (Egan & Weinberger, 2004). This mutation is related to the neurocognitive 
impairments associated with schizophrenia. This section is only a brief review of the 
literature on the genetic markers of schizophrenia. These findings and others suggest that 
schizophrenia is genetically complex, (i.e., it is caused by multiple genes located on 
multiple chromosomes).
It is commonly believed that schizophrenia is a neurodevelopmental disorder.
One o f the most popular neurodevelopmental conceptualizations of schizophrenia is 
Crow’s hypothesis (1990). Crow suggested that there is a genetically determined 
neurodevelopmental anomaly that impairs cerebral asymmetry. Because brain
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asymmetry is not completed until the end of adolescence, this anomaly in brain 
asymmetry can go relatively undetected until this point in development. The end of 
adolescence is around the same time as the typical age of onset in schizophrenia. Others 
have also suggested that schizophrenia is a neurodevelopmental disorder linked to the 
abnormal development of critical brain regions. For example, Weinberger (1987) 
suggested that schizophrenia results from disturbed brain development during the pre or 
perinatal period. Together, these studies provide strong support for a schizophrenia 
genotype that is complexly inherited and may exert its effects by causing abnormal 
cerebral development.
According to the diathesis-stress model, environmental influences are also 
important in the etiology and expression of schizophrenia. Environmental stressors 
studied as risk factors for schizophrenia have included in utero stressors, birth 
complications and even the season or place o f birth. In all cases, these risk factors are 
thought to cause early damage to the developing brain which, when combined with 
genetic predisposition, causes the expression o f schizophrenia. Schizophrenia rates are 
higher in those infants who were exposed to infectious agents prenatally (Watson et al., 
1984; Torrey et al., 1988) or viruses like influenza (Mednick et al., 1988; McGrath, 
1994). Similarly, environmental stressors like famines during pre-natal development are 
correlated with an increased incidence o f schizophrenia (Susser et al., 1996). Obstetric 
complications may also pose a risk factor for the development of schizophrenia, as 
obstetric hazards are associated with increased risk o f brain injury. In particular, infants 
bom prior to 32 weeks gestation have increased ventricular volume, corpus callosum 
abnormalities, smaller whole brain volumes, and smaller hippocampi similar to the
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neurological findings seen with individuals who have schizophrenia (Nosarti et al., 2001). 
In males with schizophrenia, low birth weight is correlated with greater cognitive deficits 
(Rifkin et al., 1994). Somewhat surprisingly, one o f the most consistent findings in 
regards to environmental influence is the season o f birth. Those bom in the late winter 
and spring are more likely to develop schizophrenia (Torrey et al., 1997). Being bom or 
raised in the city is also associated with an increased risk of developing schizophrenia 
(Lewis et al., 1992; Takei et al., 1992), possibly due to increased exposure to 
environmental toxins. Thus, there is strong support for perinatal influences as risk factors 
for the development o f schizophrenia.
Although the bulk of the research on environmental influences in schizophrenia 
has focused on perinatal factors, more recent research has suggested that early childhood 
experiences are also very important. The Finnish adoption study by Tienari (1991) 
provided compelling support for the importance of childhood experiences in the 
development of schizophrenia. In this study, adopted children of parents with 
schizophrenia had significantly different rates o f schizophrenia when raised by “healthy” 
families (4%) as opposed to children raised by “disturbed” adoptive families (34%). It is 
also believed that other measures of family function are important in predicting 
schizophrenia. Variables such as parental hostility (Rodnick, Goldstein, Lewis, & Doane, 
1984) or high expressed emotion have been associated with increased rates of 
schizophrenia and higher rates of relapse (Goldstein, 1985; Vaughn & Leff, 1976, 1981). 
Vaughn and Leff defined expressed emotion as high levels o f intmsiveness and high 
levels o f criticism. Also, criticism from family members has been correlated with 
increases in the patient’s unusual thinking (Hooley & Hiller, 1998). In fact, stressful
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events are very common before the onset o f schizophrenia (Brown & Birley, 1968; Day 
et ah, 1987; Ventura, Nuechterlein, Lukoff & Hardisty, 1989). More recently, even 
stressors such as poverty have been implicated in development of schizophrenia (Cohen, 
1993; Saraceno and Barbui, 1997), which has led to active efforts to identify life stressors 
that are substantive predictors of schizophrenia onset. One such stressor, which will be 
extensively reviewed later, is the experience of trauma. Eighty-seven percent of 
individuals with severe mental illnesses like schizophrenia have experienced at least one 
traumatic event (Goodman et al., 2001). Also, a trauma history has been correlated with 
more severe symptoms of schizophrenia and other deleterious effects (Beck & van der 
Kolk, 1987; Craine et al., 1988; Ross, Anderson & Clark, 1994). Therefore, research has 
shown that schizophrenia is a disorder that may be caused by genetic and environmental 
factors that combine to produce abnormal neurodevelopment, which is expressed as 
schizophrenia.
Neurological Function in Schizophrenia
Although schizophrenia has long been considered a disorder of the brain, 
neurocognitive testing and neuroimaging techniques have provided unequivocal evidence 
of structural and neurophysiological abnormalities. Despite the extensive amount of 
research regarding numerous neurophysiological deficits associated with schizophrenia, 
findings with regard to neurophysiological deficits are not as consistent across 
individuals as the neurocognitive deficits (Liddle and Pantelis, 2003). A meta-analysis 
evaluating brain volume in schizophrenia indicated that there is a 2% reduction in whole 
brain volume (Ward et al., 1996; Wright et al., 2000), which may be primarily gray 
matter in the heteromodal association cortex (Schlaepfer et al., 1994). Another
13
frequently discussed neurological difference in schizophrenia is a lack of normal brain 
asymmetry. Individuals without schizophrenia are more likely to have left hemisphere 
dominance, whereas individuals with schizophrenia lack this normal asymmetry (Maher 
& Deldin, 2001). In the following sections the brain structures that are most consistently 
implicated in schizophrenia will be reviewed including the temporal lobe, frontal lobe, 
and subcortical structures. Sections will include findings from both structural and 
functional neuro imaging techniques.
Temporal Lobe. The temporal lobes have been implicated in some o f the key 
schizophrenia symptoms such as hallucinations, negative symptoms and disorganized 
speech (Vignall, Maillard, McGonigal, & Chauvel, 2007; Weinstein, Woodward & Ngan, 
2007; Thomas et al., 2005). Additionally, the superior temporal gyrus has a role in the 
auditory perception and expression of language and therefore may be related to auditory 
hallucinations and formal thought disorder (Liddle & Pantelis, 2003; Petty et al., 1995). 
The most consistent neurophysiological finding in schizophrenia is enlargement of the 
ventricles (Liddle & Pantelis, 2003) and in particular the temporal horns o f the lateral 
ventricles and the third ventricle (Johnstone et al., 1976; Hopkins & Lewis, 2000). 
Examination o f the lateral temporal lobe also provides support for the deficits related to 
thought disorder as the volume in the superior temporal gyrus was inversely correlated to 
the severity of thought disorder (Shenton et al., 1992). There have also been 
abnormalities detected in the size of the temporal lobe in individuals with schizophrenia 
(Southard, 1915). The superior temporal gyrus and the planum temporale have reduced 
volume which is evident in the first episode of schizophrenia suggesting that it is not the 
result o f disease chronicity, medication effects, or other related disease variables
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(Hirayasu et a l, 1998). Results of a meta-analysis on the size o f the medial temporal 
structures (hippocampus and amygdala) revealed a bilateral reduction of 4% (Nelson, 
Saykin, Flashman, & Riordan, 1998). Bilateral reduction may not be present until later in 
the disease, while the left-hippocampal volume reduction is present at the first-episode of 
schizophrenia (Velakoulis et al., 1999). Overall, structural neuroimaging studies have 
detected abnormalities or decreased volume in superior temporal cortex and hippocampal 
regions in individuals with schizophrenia, which appear to result from both genetic and 
environmental influences.
Post mortem studies have also indicated changes in the cytoarchitecture of the 
hippocampus suggestive o f abnormal cortical migration (Jakob & Beckmann, 1986,
1994). Some o f the cellular or molecular findings include smaller neurons in the 
hippocampal region of individuals with schizophrenia compared to those of controls 
(Arnold, 2000), poorly formed and disorganized clusters o f neurons in the entorihnal 
cortex, abnormal expression of MAP2 gene, abnormal expression of mRNA products, 
and inappropriate glutamatergic and catecholaminergic innervation of the entorhinal 
cortex (Arnold, 2000).
Functional neuroimaging and ERP studies further document hippocampal 
dysfunction in schizophrenia and have also demonstrated associations between this 
dysfunction and some of the core symptoms of schizophrenia. Functional studies have 
implicated the medial temporal structures in the positive symptoms o f schizophrenia 
(Liddle & Pantelis, 2003). A decrease in the P300 wave on ERP in individuals with 
schizophrenia is correlated with thought disorder (Roth, Pfefferbaum, Kelly, Berger, & 
Kopell, 1981). Heckers et al. (1998) found reduced hippocampal activation using PET
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scans in individuals with schizophrenia during episodic memory tasks. However, other 
studies have not found significant correlations between memory performance and 
hippocampal size or function (Busatto et al., 1994). Despite some contradictory findings 
the functional studies of the temporal lobe provides additional evidence for hippocampal 
dysfunction in schizophrenia.
Limbic System. Various components of the limbic system have also heen 
extensively investigated in schizophrenia, including the hippocampus, which was 
discussed earlier, as well as the anterior cingulate and the amygdala. Limbie system 
abnormalities are thought to contribute to some of the core features of schizophrenia, 
including emotional dysregulation and blunting, attentional deficits, and impaired 
response inhibition. For example, the anterior cingulate is associated with attentional 
processes and response inhibition. Some structural neuroimaging studies have 
doeumented deereased volume of the eingulate cortex in individuals with sehizophrenia 
(Goldstein et ah, 1999). Decreased volume and lack o f normal asymmetry of the anterior 
cingulate has also been found in individuals with childhood onset schizophrenia 
(Marquardt et ah, 2005). Furthermore, there is evidenee to suggest that there is a 
reduetion in the nonpyramidal neurons in layers II-VI of the anterior cingulate in 
individuals with schizophrenia (Todtenkopf, Vineent, & Benes, 2005). Other studies 
have found no structural differences in the anterior cingulate (Hirayasu et ah, 1999), 
however the overall findings with regard to structural changes o f the anterior cingulate 
suggest that individuals with sehizophrenia have decreased volume in this region.
It would also be expected that functional studies o f the anterior eingulate would 
reveal some abnormalities in individuals with schizophrenia. Similar to the structural
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studies, functional studies are somewhat inconsistent. A meta-analysis documented 
consistent increases in the activation o f the anterior cingulate in individuals with 
schizophrenia (Glahn et al., 2005). Some single experimental studies have found 
decreases in the activation of the anterior cingulate. For example, Carter et al. (1997) 
found decreased activation of the anterior cingulate during the Stroop task in individuals 
with schizophrenia. Deficiencies of the anterior cingulate have also been correlated with 
the disorganized symptoms o f schizophrenia (Liddle et al., 1992). So while the findings 
regarding the anterior cingulate function are not conclusive, the research indicates that 
there is an overall trend towards increased activation in individuals with schizophrenia.
The amygdala is another component o f the limbic system and dysfunction in this 
structure would be associated with emotional processing deficits. MRI studies have 
shown reduced volume and reduced gray matter density o f the amygdala (Gur et ah,
2000; Breier et ah, 1992). Niu et ah (2004) found that males had bilateral reduction, 
while females had significantly smaller right amygdala. Additionally, there was a 
significant trend for the left amygdala to be smaller than the right for males with 
schizophrenia. So, while the majority of studies evaluating structural changes of brain 
regions evaluate the limbic system structures combined, ones that have specifically 
looked at the structure of the amygdala have documented decreased volume.
In conjunction with the structural deficits of the amygdala in schizophrenia, some 
functional abnormalities have also been identified. Schneider et al. (1998) found less 
activation of the amygdala in patients with schizophrenia using sad emotional prompts. 
Phillips et al. (1999) found that individuals with schizophrenia were less accurate and had 
less activation when identifying facial expressions than controls. Phillips et al. also
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found that there was a difference in activation and accuracy of identifying facial 
expression based on the subtype of schizophrenia; individuals diagnosed with paranoid 
schizophrenia were more similar to controls than those people with other types of 
schizophrenia. Taylor, Liberzon, Decker, and Koeppe (2002) reported that individuals 
with schizophrenia did not exhibit activation of the amygdala in response to aversive 
stimuli. Thus, results o f both structural and functional neuroimaging studies suggest 
impairment of the amygdala in schizophrenia.
Frontal Lobes. The frontal lobes are one of the primary brain structures 
implicated in the pathogenesis o f schizophrenia. Functions o f the frontal lobe include 
deficits in motivation, problem solving, abstraction, and decision-making. The 
localization of these abilities to the frontal lobe was primarily accomplished through 
individuals who had sustained damage to the prefrontal cortex (e.g., Shamay-Tsoory, 
Aharonj-Peretz, Levkovitz, 2007; Maher & Deldin, 2001). This literature has been linked 
to the deficits associated with schizophrenia. In individuals with schizophrenia, 
structural MRI studies have shown decreased volume of the frontal lobe (Andreasen et 
ah, 1994, Breier et al., 1992, Nopoulos et al., 1995). Volumetric analyses indicate that 
the majority of the reduction is the result of grey matter loss in the dorsolateral and 
dorsomedial prefrontal cortex (Goldstein et al., 1999). The deficits in prefrontal volume 
may be caused by abnormalities in the composition or number o f neurons (Liddle & 
Pantelis, 2003). The frontal lobe abnormalities are also found early in the progression of 
the disease (i.e., in those experiencing their first episode o f the disorder that has never 
been medically treated) and are therefore interpreted by some as a central component in 
schizophrenia.
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It is generally believed that the frontal lobe abnormalities seen in schizophrenia 
reflect a decrease in activity and correspondingly, functional neuroimaging studies have 
demonstrated this hypoactivity in the frontal lobe. Both PET and fMRI studies indicate 
that individuals with schizophrenia demonstrate hypoactivity in the prefrontal cortex 
while performing traditional tests of executive function, such as the Tower of London and 
Wisconsin Card Sorting Test (Andreasen et al., 1992; Kawasaki et al., 1993; Weinberger 
& Berman, 1996). In line with the idea that the pattern of activation is impaired in 
individuals with schizophrenia, Meyer-Lindenberg et al. (2001) found that controls 
exhibited dorsolateral prefrontal and anterior cingulate activity during working memory 
tasks, while all o f the individuals with schizophrenia had inferotemporal, hippocampal 
and cerebellar activation during the same tasks. These findings could be interpreted to 
mean that as a result of prefrontal cortex dysfunction, individuals with schizophrenia 
recruit other brain structures to perform these tasks, which results in inefficient 
performance and neurocognitive deficits. Futhermore, fMRI studies of the frontal lobes 
have also suggested abnormal dopamine function in individuals with schizophrenia 
during working memory tasks (Meyer-Lindenberg, Poline, Kohn et al., 2001). The 
hypofrontality indicated by functional imaging studies may not be present through all 
phases of the illness and appears to be associated with specific symptoms o f the disorder 
(Liddle, 1996). Decreased activity in the frontal lobes may be preferentially related to the 
negative symptoms in schizophrenia. Hypoactivity in the prefrontal cortex has also been 
associated with psychomotor poverty syndrome in schizophrenia (Liddle, 1996). ERP 
results have, however, linked frontal abnormalities to both the positive and negative 
symptoms o f schizophrenia (Pritchard, 1986; van den Bosch et al., 1988). In conclusion.
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neuroimaging techniques provide strong evidence for both structural and functional 
abnormalities in the frontal lobes, and particularly the dorsolateral and dorsomedial 
prefrontal cortices.
Basal Ganglia. The basal ganglia have also been of interest in schizophrenia 
research because of the high prevalence of movement disorders in this population. 
Among other things, the basal ganglia are responsible for controlling motor movements 
and smoothing fine motor behavior. The basal ganglia are made up of at least five 
subcortical nuclei including the putamen and globus pallidus (which are collectively 
called the lentiform nucleus), caudate nucleus, nucleus accumbens, septi, and olfactory 
tubercle. Damage to these structures can result in both hypokinetic movement 
disturbances, such as those observed in Parkinson’s disease, as well as hyperkinetic 
movement disturbances, such as those present in Huntington’s Chorea. Both hypokinetic 
and hyperkinetic movement disorders are present in those with schizophrenia, some 
resulting from treatment with antipsychotic medications, and others that are present prior 
to the onset o f the disorder.
Structural neuroimaging studies have implicated a number of basal ganglia 
structures involved in schizophrenia. And, while some behavioral studies have 
documented clear neuromotor and movement disorders in children who later go on to 
develop schizophrenia (Schiffman, Walker, Ekstrom, Schulsinger, Sorensen, & Mednick, 
2004; Walker, Savoie, & Davis, 1994; Walker, Lewis, Loewy, & Palyo, 1999), 
neuroimaging studies suggest that movement disorders may primarily result from the 
medication used to treat schizophrenia. McCreadie, Thara, Padmavati, Srinivasan, and 
Jaipurkar (2002) found volumetric differences of 11% in the left lentiform nucleus in
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those individuals with schizophrenia that also exhibited movement disorders. Gunduz et 
al. (2002) did not find any difference in the volume o f the basal ganglia structures in 
individuals with their first episode of psychosis. Gunduz et al. also did not find any age 
related differences and suggested that the volumetric differences seen in individuals with 
schizophrenia may be related to illness progression or use of antipsychotic medications.
In fact, studies have shown that when compared to controls, individuals with 
schizophrenia who are treated with typical neuroleptics have larger basal ganglia, 
whereas those treated with atypical neuroleptics have decreased basal ganglia, caudate 
and lenticular nucleus (Corson, Nopoulos, Miller, Arndt, & Andreason, 1999). Structural 
evidence suggests that the basal ganglia may be damaged by the medication used to treat 
schizophrenia. Functional neuroimaging studies also reveal that the basal ganglia 
function abnormally in individuals with schizophrenia. SPECT and PET studies have 
suggested that in schizophrenia the basal ganglia have excessive amounts of dopamine 
because after administration of amphetamine, displacement of radioactive ligands binding 
to dopamine are released more than in controls (Lamelle et al., 1996). Thus, it appears, 
that the basal ganglia are overactive in individuals with schizophrenia, most likely 
resulting from excess dopamine of antipsychotic medication used to treat schizophrenia.
Neurocognitive Deficits. Neurocognitive deficits are a direct expression of brain 
dysfunction and provided strong evidence for the presence of cerebral dysfunction long 
before current neuroimaging techniques were available. However, a challenge for 
neurocognitive research has been to identify differential deficits, (i.e., those deficits that 
are uniquely impaired) within the context o f a more general and pervasive pattern of 
diminished cognitive abilities often observed in schizophrenia. These differential deficits
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are of particular importance because they provide an indication o f brain regions and 
neural circuits that are particularly susceptible in schizophrenia. Differential deficits 
consistently identified include memory, executive function, attention, planning and 
abstraction, which will be reviewed in the following sections.
Memory is viewed as one of the major cognitive deficits in individuals with 
schizophrenia and is often differentially impaired. Current prevailing theories of memory 
function have provided a variety of terms for various memory constructs. Some are 
relatively independent of each other, and others that substantially overlap. One of the 
oldest conceptualizations of memory is based on the duration of memory retention, and 
includes three primary memory stores, a sensory store, short-term store, and a long-term 
store. In the sensory store, information is accessible for milliseconds and is the first store 
in which information is registered. Relevant information from the sensory store is passed 
to the short-term memory store, which has a limited capacity (7 + 2 pieces of 
information) and in which information is lost if  not rehearsed after several seconds.
Some information from the short-term store is passed to the long-term store, where it may 
remain indefinitely. In addition to these basic concepts, many other memory constructs 
have been identified, and some have been linked to specific brain regions. Figure 1 
provides a schematic drawing of the different types of memory and the primary brain area 
associated with each type.
More recently, the concept of working memory has come to replace the construct 
of short-term memory. The working memory store is a short-term memory store in 
which information can be manipulated. Baddeley (1974) proposed three components in 
working memory, including the central executive, phonological loop and the visuospatial
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sketchpad. As the name implies, the central executive is believed to control the 
phonological loop and the visuospatial sketchpad. The phonological loop codes acoustic 
information, while the visuospatial sketchpad codes visual information. Within long­
term memory, there are two primary types; explicit (declarative) memory and implicit 
(non-declarative) memory. Explicit memory can be further subdivided into semantic and 
episodic memory (Tulving, 1989). Episodic memory refers to the autobiographical 
memories that a person has of what things or events have happened to them (Kolb & 
Whishaw, 2001).
On the other hand, semantic memory is considered general knowledge or the 
ability to remember meanings and facts (Kolb & Whishaw, 2001). Implicit memory is 
learning without conscious knowledge. Implicit memory includes skills and habits, 
priming, classical conditioning and non-associative learning (reflexes). While emotional 
responses may fall under the heading of classical conditioning, many theorists have 
proposed that emotional memory may be another type of memory with components of 
explicit and implicit memory (Schachter, 1987). It may be assumed that some aspects of 
emotional memory rely on the implicit memory system (i.e., emotional “tagging” of life 
events) while others are consistent with explicit processing (i.e., remembering an 
emotional face).
These types o f memory differ according to the type of thing to be remembered, 
and also in how and where they are processed in the brain. The entorhinal cortex, 
parahippocampal cortex, and the perirhinal cortex make up the medial temporal cortical 
regions (Kolb & Whishaw, 2001). This area, along with the hippocampus and the 
amygdala, is responsible for explicit memory. There is a reciprocal connection between
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these areas and the neocortex. This builds and maintains a neural record. The amygdala 
seems to be the primary brain area responsible for emotional memory. The amygdala has 
very close connections to the medial temporal structures and the hypothalamus (Kolb & 
Whishaw). In implicit memory, the basal ganglia receive input from the entire cortex and 
the substantia nigra, which is rich in dopamine, and then sends projection to the ventral 
thalamus and then to the premotor cortex. While, the frontal lobe has connections to the 
medial temporal regions, it does not play a large role in explicit or implicit memory.
Figure 1
Graphic description of the different types of memory and the underlying neurological 
structures (Adapted from Thompson, 2001).
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The frontal lobe is the primary site for working memory. As such, working memory 
findings in regard to schizophrenia will be discussed in conjunction with findings 
regarding the neurocognitive function of the frontal lobes.
Aleman, Hijman de Haan, and Kahn (1999) conducted a meta-analysis of the 
memory deficits associated with schizophrenia and found that memory was significantly 
impaired. Long-term recall measures yielded a d = 1.21 effect size. Performance was 
improved in cue conditions, but still significantly different than controls. Nonverbal 
memory was also not as impaired as verbal memory, but both were still significantly 
worse in individuals with schizophrenia compared to controls. There were no differences 
in immediate versus delayed recall conditions. Sullivan et al., (1992) have suggested that 
the declarative memory deficits associated with schizophrenia may be related to poor 
organizational strategies. A recent meta-analysis of recognition memory suggests that 
recognition memory is significantly impaired in individuals with schizophrenia (d = .76) 
and that figurai memory is more impaired than verbal memory (Pelletier, Achim, 
Montoya, Lai & Lepage, 2005). Additionally, chronicity of the disease resulted in more 
memory impairment.
Individuals with schizophrenia also have deficits in attention as measured by such 
tasks as the CPT (Knight & Silverstein, 1998). The attention deficits seen in 
schizophrenia are so consistent that the CPT has also been proposed as a biochemical 
marker for schizophrenia. Longitudinal studies o f  individuals at risk for schizophrenia 
have found childhood deficits on CPT performance in those who later go on to develop 
schizophrenia (Comblatt & Keilp, 1994; Nuechterlein, et al., 1992). Furthermore, the 
CPT can be used to differentiate individuals with psychosis or formal thought disorder
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(Nelson, Sax & Strakowski, 1998). Poor performance on the CPT can be related to an 
impairment in contextual processing (Cohen & Servan-Schreiber, 1992), deficits in 
perceptual organization, or problems with working memory (Knight & Silverstein, 1998).
As expected, individuals with schizophrenia have difficulty on other measures of 
attention including the oddball task (Kogoj, Pirtosek, Tomori & Vodusek, 2005). 
Individuals with schizophrenia also exhibit impairment on other neurocognitive tasks 
with an attentional component including digit span, spatial span, letter number 
sequencing. The Trail Making Test and the WCST (Heinrichs & Zakzanis, 1998).
During the oddball task, individuals with schizophrenia had difficulty-reorienting 
resources away from the primary task and were more susceptible to distraction than 
controls (Laurens, Kiehl, Ngan, & Liddle, 2005). Individuals with schizophrenia are 
consistently found to exhibit impairment on attentional measures.
The structural and functional deficits in the prefrontal cortex can cause 
impairment of executive function and working memory abilities (Baare et ah, 1999). 
Executive function includes planning, abstraction, working memory, and decision­
making. On the Wisconsin Card Sort Test, a measure o f executive function, individuals 
with schizophrenia make more perseverative errors and achieve fewer categories correct 
(Goldberg, Torrey, Gold et ah, 1995). Individuals with schizophrenia are also impaired 
on many other measures o f executive function including The Trail Making Test B and the 
Stroop (Liddle and Morris, 1991). Individuals with schizophrenia have shown 
impairment on some of the most sensitive measures o f abstraction and problem-solving 
including the Halstead Category Test, Part B of the Trail Making Test and the Halstead 
Tactual Performance Test (Goldstein, 1990). Verbal fluency is another measure of
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executive function that is impaired in individuals with schizophrenia (Allen, Frith, & 
Liddle, 1993). Allen, Frith, and Liddle (1993) further suggest that the verbal fluency 
deficits associated with schizophrenia do not reflect the number of words stored, but the 
ability to access stored words. Working memory is the last category o f cognitive tests 
representative o f frontal lobe function. Working memory deficits have also been noted in 
individuals with schizophrenia (Fleming, Goldberg, Gold and Weinberger, 1995; 
Spindler, Sullivan, Menon, Lim, and Pfefferbaum, 1997; Sullivan, Shear, Zipursky, Sagar 
and Pfefferbaum, 1997), although it has been less clear which component of working 
memory was impaired. Spindler et al. determined that the working memory deficits seen 
in schizophrenia were the result o f failure in multiple independent systems, rather then a 
problem with the central executive. Fleming and colleagues determined that working 
memory deficits are associated with limited processing resources. Contrary, to Spindler 
et al., Fleming et al. believed that the deficit in working memory was accounted for by a 
central executive because even during distractor tasks that could be considered 
semiautomatic, like counting, individuals with schizophrenia were more impaired than 
controls. Also of note, Fleming et al. found that individuals with schizophrenia made 
significantly more intrusion errors than controls. For working memory tests, as task 
difficulty increases, patients with schizophrenia attempt to compensate for neurological 
deficiencies by utilizing additional brain areas (Callicott, Bertolino, Mattay et ah, 2000).
It has also been suggested that the deficits in the prefrontal cortex o f individuals with 
schizophrenia may contribute to explicit memory impairment (Goldman-Rakic, 1991). 
Overall, individuals with schizophrenia have impairment in a wide range of executive 
functions.
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Basal ganglia impairment would be presumed to contribute predominantly to 
impairment in motor tasks. It could, however, be hypothesized that basal ganglia 
impairment may contribute to poor performance on measures o f frontal lobe activity.
The literature does show that individuals with schizophrenia do poorly on tests of motor 
function including finger tapping and The Trail Making Test A (Yang et al., 2004; Muller 
et al., 2002).
In conclusion, individuals with schizophrenia exhibit a wide range of 
neuropathological and neurocognitive deficits. There is a reduction in the whole brain 
volume and grey matter volume in individuals with schizophrenia. Individuals with 
schizophrenia also lack normal brain asymmetry. Structural imaging studies have found 
that the hippocampus, anterior cingulate, amygdala, and frontal lobes are smaller in 
individuals with schizophrenia than in those without schizophrenia. There is also 
evidence to suggest that the neuronal formations are different in individuals with 
schizophrenia, particularly in the hippocampus. Functional imaging studies indicate 
decreased function in the hippocampus, amygdala and frontal lobes, while the anterior 
cingulate appears to have increased activation in individuals with schizophrenia. 
Neurocognitive tests reveal impairment across memory function, executive function, 
attention, emotional processing, and motor function in those with schizophrenia. 
Post-Traumatic Stress Disorder
Post-traumatic stress disorder (PTSD) is the most common diagnosis given to 
individuals who have been exposed to a traumatic event. Individuals with PTSD often 
alternate between feeling numb and detached from others to being flooded with emotion.
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To qualify for a diagnosis of PTSD people exposed to a traumatic event must also 
experience some symptoms of hyperarousal, avoidance, and memory intrusions.
Sixty percent of Americans will be exposed to a traumatic event in their lifetime 
with many of those experiencing more than one traumatic event (Kessler et ah, 1995). 
Identification and treatment of people who have experienced trauma and are having 
symptoms may help prevent the onset of PTSD. If untreated, 40% of people with PTSD 
symptoms in the wake of a traumatic event will go on to develop PTSD (Craine, Henson, 
Colliver & MacLean, 1988). O f those people with symptoms that received no treatment, 
remission time was increased from three to five years (Craine, Henson, Colliver & 
MacLean, 1988) and some may never recover (Friedman, 2001). Those individuals who 
continue to have symptoms may have more severe symptoms as time progresses and 
there is increased risk of developing secondary disorders (Nathan & Gorman, 2002). 
Current estimates of PTSD prevalence range from 5% to 14% in the United States 
(Breslau et al., 1998), with 8% generally agreed upon as the lifetime prevalence rate 
(Kessler et al., 1995).
A number of risk factors have been identified that predict who will or will not 
develop PTSD. Gender and type o f trauma are usually considered the primary factors in 
determining who will develop PTSD after exposure to a traumatic event. In general, 
women are two times more likely than men to develop PTSD. Gender also influences the 
kind of traumatic event that one may experience. For example, men are most likely to 
experience trauma by witnessing a crime, being involved in an accident, or being 
threatened with a weapon. On the other hand, women are most likely to have been a 
witness to a crime, to be involved in an accident or to be molested.
29
The type of trauma experienced is also associated with different rates o f PTSD. 
For example, witnessing a traumatic event and surviving a natural disaster have lower 
rates of PTSD than trauma involving personal attacks. One potential explanation for 
higher rates of PTSD associated with personal attacks is that they are directed at the 
individual. Also when a natural disaster occurs there are usually groups of people who 
were all exposed to the traumatic event at the same time allowing for more social support 
and communication, which can aid in healing. Within the types o f trauma that involve 
personal attacks, torture survivors (Nathan & Gorman, 2002) and rape survivors have the 
highest rates of PTSD (Kessler et al., 2000). Broken down according to gender, rape is 
identified as the most traumatic event for both men and women (Kessler et al., 1995). 
There is also evidence to suggest that those individuals exposed to chronic trauma or that 
have been traumatized on more than one occasion are more likely to exhibit PTSD 
symptoms (Allen, 1995).
Other well-cited factors influencing the development o f PTSD are the severity of 
the abuse, history of abuse, lower intelligence, earlier age at time of trauma, lack of social 
support, and genetic or personal history of psychiatric disorder (Nathan and Gorman, 
2002). The most predictive psychological factor leading to cognitive impairment is the 
victim reporting that she feared for her life during the traumatic event (Sheiman, 1999). 
Additionally, a close association with the perpetrator may also lead to more 
psychological impairment (Lawyer, Ruggierio, Resnick, Kilpatrick & Saunders, 2006).
In regards to determining who will develop PTSD, there are some researchers to 
suggest that individuals who develop PTSD may have had pre-existing 
neurophysiological deficits making them more susceptible to the development of PTSD.
30
For example, while many studies have found decreased hippocampal volume in adult 
survivors o f trauma, it is unclear whether the decreased volume preceded the onset of the 
trauma or vice versa (Stein, Koverola, Hanna, et al., 1997; Villarreal, Hamilton, 
Petropoulos, et al., 2002). Two studies have provided some evidence suggesting that 
hippocampal shrinkage may be a direct long-term effect o f stress. The first study did not 
find loss o f hippocampal volume in children with PTSD (DeBellis, Hall, Boring et al.,
2001). The second study did not find any difference in hippocampal volume at 1 week or 
6 months post-trauma suggesting that hippocampal reduction is not present prior to the 
onset o f PTSD (Bonne et al., 2001). On the other hand, a study by Gilbertson et al., 
(2002) found decreased hippocampal volumes in noncombat twins of combat veterans 
with PTSD, suggesting that hippocampal volume may be a predisposition for 
development of PTSD. There is also research investigating whether differences in 
gamma amino butyric acid (GABA) may be present prior to the trauma and if they are 
predictive o f who will develop PTSD. Vaiva et al., (2004) suggested that low levels of 
GABA may predict the onset o f PTSD. Vaiva et al., measured plasma GABA levels 
immediately following traffic accidents and low GABA levels were correlated with 
higher Clinician Administered PTSD Scale (CAPS) scores. So, while there is still 
evidence to suggest that the physiological changes were present prior to the trauma and 
predictive of who will develop PTSD, the majority of the research suggests that 
physiological changes are a direct result of trauma.
As suggested in studies regarding chronic stress in animals, there are several 
changes that occur physiologically in response to stress that may be responsible for the 
associated cognitive deficits (Rasmusson and Chamey, 1995). However, the
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neuropathological and cognitive changes associated with stress have been more 
consistently identified in those with PTSD than in trauma survivors without a diagnosis 
of PTSD. The pathophysiological changes that occur after trauma may also be dependent 
on how severe or chronic the trauma, and the stage of development in the organism at the 
time when the trauma occurred. At this time, the underlying mechanisms contributing to 
the development of PTSD are unclear, as are how long after a trauma these changes 
persist. Fortunately, there is evidence to suggest that the physiological changes resulting 
from stress can be resolved with medication (Seedat, 2001).
In order to discuss the behavioral and cognitive changes resulting from a 
traumatic event, a discussion of the basic stress response will follow, with a discussion of 
the neurohormonal, neurotransmitter, and neurological changes associated with PTSD.
Stress Hormones, Neurotransmitters and PTSD
Cannon (1928) and Selye (1936) were the first to describe the impact of stress on 
an organism. They noted that the body would begin a series of reactions which may 
involve the cessation of current activity, most commonly termed the fight or flight 
response. Additional research has not only confirmed these effects, but has also included 
the sympathetic nervous system, hypothalamic-pituitary-adrenal axis (HPA), and 
endogenous opiates. Upon initiation of the fight-or-flight response the hypothalamus 
releases corticotropin releasing factor (CRF), which then activates the neurons in the 
locus coeruleus. CRF also mediates fear-related behavior and stimulates other 
neurochemical responses like the noradrenergic system (Bremner & Vermetten, 2001). 
The neurons of the locus coeruleus then activate the hypothalamus, amygdala, 
hippocampus and cerebral cortex. At the same time CRF released from the hypothalamus
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will also stimulate the pituitary to release adrenocorticotropic hormone (ACTH). ACTH 
then stimulates the adrenal gland to release cortisol, which will then have a negative 
effect on the axis at the pituitary and at the hypothalamus and hippocampus (Duman, 
1995). This is the most discussed response to stress and is termed activation of the HP A 
axis. The HP A axis is then hyper-reactive, meaning that there are increased 
concentrations of CRF throughout the brain and spinal fluid (Arborelius, Owens, Plotsky 
& Nemeroff, 1999).
The aforementioned cascade of events has at least two important ramifications for 
PTSD. The first of which is that the stress response may somehow permanently alter the 
neurophysiology of the organism. If  the adverse events are early, they can cause 
permanent damage to the HP A axis (Bremner & Vermetten, 2001). Long-term changes 
of the serotonergic system are associated with chronic stress, particularly in the 
hippocampus (Bremner & Vermetten, 2001). Even minor stressors have been 
documented to alter neuronal biology through activation of transcription factors (Daval, 
Nakajima, Gleiter, Post, & Marangos, 1989). As one might expect, cognitive and 
behavioral changes will accompany physiological changes associated with stress.
Individuals exposed to chronic stress or a more severe stressor (traumatic event) 
can experience cognitive, affective and behavioral changes that are attributed to the stress 
response (Arborelius, Owens, Plotsky & Nemeroff, 1999). Memory is the cognitive 
ability that is particularly susceptible to fluctuations in these neurochemicals. Peptides, 
like adrenocorticotropic hormone (ACTH) and vasopressin, can strengthen memory, 
perhaps because of their role in long-term potentiation. Norepinephine (NE) may 
strengthen or weaken the memory trace of the trauma and has direct input to the
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amygdala. Administration of norepineprhrine or epinephrine in animals increases recall 
o f emotional material (Cahill & McGaugh, 1998). Adrenaline may strengthen memory 
traces at least temporarily (Elzinga & Bremner, 2002). On the other hand, cortisol may 
inhibit memory traces (Elzinga & Bremner, 2002). Overall, it has been shown that 
cortisol has a long-term effect of impairing memory (Kirschbaum et al., 1996). High 
levels o f glucocorticoids can interfere with learning (Bremner & Vermetten, 2001). 
Memory and learning deficits may be mediated by other neurochemicals, including: 
brain-derived neurotrophic factor (BDNF), endorphins and oxytocin (van der Kolk, 
1994). Neurohormonal changes then influence noradrenergic, serotonergic, 
gabaminergic and dopaminergic neurotransmitters.
CRF intemeurons are widely dispersed throughout the brain and are heavily 
concentrated in both the locus coeruleus and raphe nuclei, the origins for the 
noradrenergic and serotonergic pathways, both o f which can be implicated in the 
behavioral and cognitive changes associated with PTSD (Arborelius, Owens, Plotsky & 
Nemeroff, 1999). Increased noradrenergic activity in the locus coeruleus increases over 
time resulting in behavioral sensitization. The overactive noradrenergic system resulting 
from stress is sensitive to even minor changes in the periphery o f the body explaining the 
physical symptoms associated with anxiety in many individuals who have PTSD 
(Chamey, Bremner, & Redmond, 2000). The noradrenergic response o f the locus 
coemleus can be associated with behavioral and cognitive changes after acute stress 
including: sleep problems, hypervigilance, irritability, anger and memory (Kimble & 
Kaufman, 2004).
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The raphe nuclei are the location where the serotonergic system originates. There 
are efferents out to most o f the brain, but serotonergic efferents are most heavily 
concentrated in the adrenergic and HP A system. The serotonergic system plays a 
significant role in learning and sensitization (Friedman, 2001). The serotonergic system 
is also implicated in depression, sleeping, eating and aggression. In PTSD, fear 
sensitization (Hensman et al., 1991) and depression (Davies et al., 1997) are the chief 
symptoms associated with the serotonergic system. While the serotonergic system has 
not received as much attention as the noradrenergic or gabaminergic system in PTSD, 
many o f the available psychopharmacological treatments for PTSD will affect the 
serotonergic system.
The dopaminergic system has its origin in the substantia nigra and has efferents to 
the frontal cortex, substantia nigra, cerebellum, and temporal lobe. While the main 
function of the dopaminergic system is movement, dopamine is also the primary 
neurotransmitter in the brain’s “reward center”. The dopaminergic system in the medial 
prefrontal cortex also appears to be particularly sensitive to the effects of stress (Bremner 
and Vermetten, 2001) and should therefore exert the most influence on working memory 
and emotional responses. In PTSD, the behavioral symptoms o f paranoia and 
hypervigilance may be mediated by the dopaminergic system.
Gamma-aminobutyric acid (GABA) has been widely discussed in conjunction 
with stress and PTSD. During acute stress, the number of GABA binding sites is reduced 
and benzodiazepine binding sites are increased (Horger & Roth, 1995; Bremner & 
Vermetten, 2001). When there is active physiological coping, GABA is enhanced, and 
emotional memory is impaired. When there is lack o f coping (lack of physiological
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response), GABA is reduced and emotional memory is especially vivid. This change in 
memory is because the GABA receptor has an anti-anxiety release receptor. Increases in 
GABA enhance release of the anti-anxiety compound. The GABA molecule has a 
binding site for sedative-hypnotics and benzodiazepines in addition to the GABA binding 
site. These two other binding sites on the GABA molecule may mediate some of the 
changes associated with stress. For example, it has been noted that taking a GABA- 
stimulating drug before the occurrence of a traumatic event can decrease the likelihood of 
developing PTSD (Maes et al., 2001). Studies have also shown that benzodiazepine 
binding may be able to cause a situational amnesia associated with stress. Results of 
animal studies indicate a decrease in benzodiazepine binding primarily in the frontal 
cortex and the hippocampus (Bremner and Vermetten, 2001). In humans, ligand 
neuroimaging, found a 41% decrease in benzodiazepine binding in individuals with 
PTSD (Bremner, Innis, Southwick et al., 2000). Decreases in benzodiazepine binding in 
the prefrontal cortex may be related to emotional processing, whereas decreases in 
benzodiazepine binding in the hippocampus could translate to memory difficulties. In 
conclusion, GABA appears to be a particularly important neurotransmitter for the 
cognitive and behavioral changes associated with stress.
Structural and Functional Brain Abnormalities in PTSD
The remainder of the PTSD section will go on to give a brief description of the 
primary tasks associated with the limbic system structures and the prefrontal cortex 
followed by a discussion o f the relevant structural and functional changes associated with 
PTSD. The last section will be a discussion of the cognitive deficits associated with 
PTSD. The cognitive section will be broken down based on cognitive domains.
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The Limbic System. The limbic system is responsible for our emotional responses, 
hormones, motivation, pain and pleasure sensation and memory. The limbic system is 
comprised o f the hypothalamus, hippocampus, amygdala, cingulate gyrus, olfactory 
cortex, thalamus and fomix. It is believed that the noradrenergic response during the 
stressor influences the limbic system to be hypersensitive, thereby disrupting the normal 
activities of the limbic structures (Everly & Horton, 1998).
The hippocampus is an area of the brain that is involved in both memory and 
emotion. Since the hippocampus connects, organizes, and locates explicit memory, the 
stress caused by trauma may lead to a distortion or fragmentation o f these memories 
(Bremner, 2002). The hippocampus is also responsible for dealing with the body’s stress 
response, particularly in reducing cortisol levels (Bremner & Narayan, 1998). Both 
structural and functional abnormalities have been reported for the hippocampus in PTSD.
Magnetic resonance imaging studies (MRI) have revealed that survivors of rape 
suffering from PTSD have diminished right hippocampal volume (Stein, Koverola, 
Hanna, Torchia, & McClarty, 1997). Right hippocampal reductions were also found in 
recent trauma survivors with PTSD (Wignall et al., 2004). Left hippocampal reduction 
has been found in PTSD patients that were abused in childhood, while PTSD patients 
traumatized in adulthood had bilateral or right hippocampal atrophy (Seedat, 2002). 
Bremner, Randall, Vermetten et al., (1995) found an 8% reduction o f hippocampal 
volume in veterans with PTSD. Subsequently, Bremner, Randall, Vermetten et al.,
(1997) found a 12% reduction o f left hippocampal volume in people with PTSD due to 
childhood abuse as compared to people with a childhood abuse history without a 
diagnosis o f PTSD. Gurvits et al., (1996) also found a reduction in hippocampal volume
37
for veterans with PTSD. There have been some studies that have not found a difference 
in hippocampal volume in individuals with PTSD (Bonne, et al., 2001; Gilbertson et al., 
2002; Neylan et al., 2004). Nutt and Malizia (2004) suggested that any null findings in 
regards to hippocampal volume and PTSD may be related to hemispheric differences. 
Nutt and Malizia hypothesized that patients with reductions in right hippocampal volume 
have more memory deficits whereas left sided deficits are associated with more 
dissociation. Overall, evidence suggests that hippocampal volume is reduced in 
individuals with PTSD.
Functional brain imaging studies of the hippocampus and associated areas in 
individuals with PTSD have also yielded some interesting results. Bremner et al., (1999) 
found decreased cerebral blood flow in the right hippocampus and supramarginal gyrus 
o f individuals with PTSD. The PET scans utilized a neutral script and a personalized 
account o f the individual’s childhood abuse. Conversely, Shin et al., (1999) found 
increased cerebral blood flow in the anterior temporal poles in individuals with a trauma 
history using similar stimuli. The PTSD group experienced the greatest increases in the 
anterior temporal pole (Shin et al., 1999). Overall, the functional differences in the 
medial temporal lobe of individuals with PTSD are not as strong as the structural 
findings.
The amygdala is the primary structure in emotional memory. The amygdala 
assigns feelings o f significance to sensory input and then the neocortex elaborates and 
assigns personal meaning (van der Kolk, 1994). Studying the amygdala is difficult 
because while the amygdala may be responsible for encoding the specific
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autobiographical trauma material it may not be responsive to general trauma material or 
during retrieval of trauma material (Hull, 2002).
The structural findings regarding the amygdala in PTSD are inconclusive. 
Bremner et al., (1997) found that survivors of childhood sexual abuse with PTSD had a 
trend towards larger amygdala. Wignall et al., (2004) performed a structural analysis of 
people recently exposed to a traumatic event with PTSD and did not find any differences 
in the size of the amygdala. Bremner et al., (1997) did not find any structural differences 
in the size of the amygdala in adult survivors of childhood abuse with PTSD. Teicher et 
al., (2002) found reductions in the size of the amygdala. Matsuoka, Yamawaki, Inagaki, 
Akechi, and Uchitomi (2003) found smaller amygdala in cancer survivors with intrusive 
thoughts. The majority of structural findings have found no difference in the size of the 
amygdala in individuals exposed to a traumatic event.
Functional findings regarding the amygdala show that the amygdala is hyper- 
responsive to fearful stimuli in PTSD. Positron emission tomography (PET) scans have 
revealed that the amygdala is exceptionally active while the survivor is reliving the 
traumatic memory (Emilien, Penasse, Charles, Martin, Lasseaux & Waltregny, 2000). 
Using a masked face paradigm and fMRI, Rauch et al., (2000) could distinguish those 
people with and without PTSD based on the magnitude o f the amygdala response with 
75% sensitivity and 100% specificity. Several studies have noted right-sided activation of 
the amygdala in individuals with PTSD during recall of traumatic material (Shin et al., 
1997: Rauch 1996). Shin et al., (2004) found that female nurse veterans with PTSD did 
not have significant activation of the amygdala, but the male combat veterans did. 
Liberzon et al., (1999) found bilateral amygdala activation along with activation in the
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other expected limbic areas utilizing auditory sound activation. The amygdala activation 
was specific to PTSD patients and did not occur in controls or in veterans without PTSD 
(Liberzon et al., 1999). Gilboa et al., (2004) utilizing a PET scan with rCBF analysis has 
shown that the intrusive re-experiencing in PTSD does not involve a failure of cingulate 
inhibition, but represents an overactive amygdala. Other studies have found no amygdala 
activation utilizing trauma probes (Bremner et al., 1999; Shin et al., 1999). These 
discrepancies may be due to the study design, type of trauma, or imaging techniques 
(Pissiota et al., 2002). Pissiota also suggests that the lateralization of fear activation in 
the amygdala may be related to perceptual (right) or cognitive representations (left). 
Overall, research suggests that the amygdala is overactive to traumatic stimuli in 
individuals with PTSD.
The cingulate gyrus is responsible for filtering memories and integrating sensory 
experience with cognitive experience. The anterior cingulate has been subdivided based 
on cytoarchitecture and connectivity into a dorsal, cognitive-motor division, a rostral, 
affective division, and a ventral, viscero-motor division (Rauch et al., 2003). In PTSD, 
significant volumetric decreases have been found with MRI in the rostral and ventral 
parts of the anterior cingulate suggesting that although the amygdala is hyperresponsive 
to threat related stimuli, it is exacerbated by insufficient inhibition from the pregenual 
and subcallosal cortex (Rauch et al., 2003). Araki et al., (2005) also found decreases in 
the anatomical size o f the anterior cingulate in individuals with PTSD from a Tokyo 
subway attack. The decreased anterior cingulate volume was correlated with lower P300 
amplitudes in an oddball task (Araki et al., 2005). Neuronal loss in the anterior cingulate 
was also found in a study of children with PTSD (DeBellis, Keshaven, Spencer, Flail,
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2000). Although there are only a limited number of studies, they all suggest a decrease in 
the volume of the anterior cingulate.
Functional imaging studies reveal hypoactivation in the anterior cingulate. Hull 
(2002) found decreased activation in the anterior cingulate, potentially explaining the 
reason why people with PTSD are unable to extinguish fear. Yang, Wu, Hsu, and Ker 
(2004) did not find activation of the anterior cingulate in earthquake survivors with 
PTSD, while those earthquake survivors without PTSD had activation of the anterior 
cingulate. Bremner et al. (2004) found that women with abuse related PTSD had a 
decrease in anterior cingulate blood flow on PET scan during the Emotional Stroop task. 
Shin et al., (2001) found that the PTSD group had a diminished response of the rostral 
anterior cingulate in response to traumatic stimuli. While the anterior cingulate is not 
especially active in patients with PTSD the posterior cingulate is (Hull, 2002). The 
activation of the posterior cingulate may be related to processing emotional information. 
Accordingly, Lanius et al., (2004) found that the patients with PTSD had greater 
activation in the posterior cingulate gyrus, while those people without PTSD had greater 
activation in the anterior cingulate gyrus. PET studies have also revealed increased 
activation of the posterior cingulate and motor cortex without activation of the medial 
prefrontal cortex and anterior cingulate in women that had histories of child abuse when 
read a script of the abuse (Shin, McNally, Kosslyn et al., 1999). While most studies 
suggest that the anterior cingulate contributes to PTSD by it’s inability to regulate the 
amygdala, Gilboa et al., (2004) using a functional path analysis determined that the 
anterior cingulate in PTSD is related to the “modulation of the structures involved in
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autonomie control rather than the amygdala itse lf’. Results of physiological studies 
indicate that the anterior cingulate is a core component in PTSD.
Medial Prefrontal Cortex. The other brain area implicated in many o f the 
symptoms experienced by trauma survivors is the medial prefrontal cortex. The medial 
prefrontal cortex is attributed with regulating emotional responses, inhibiting competing 
memories, planning, organization, filtering and inhibition. Collectively many of the tasks 
performed by the medial prefrontal cortex are termed executive function.
There is no research to suggest that there are structural alterations in the prefrontal 
cortex in individuals with PTSD. The functional findings regarding the prefrontal cortex 
are, however, the most replicated physiological finding in PTSD (Bremner, 2002).
Gilboa et al., (2004) have determined that in individuals with PTSD the amygdala exerts 
greater influence over the medial prefrontal cortex than in those without PTSD. “Women 
with abuse related PTSD had a decrease in medial prefrontal blood flow during recall of 
stressful word pairs” (Bremner et al., 3/1/01 as cited in Bremner and Vermetten, 2001). 
SPECT studies have shown an increased regional cerebral blood flow (rCBF) in fhe 
medial prefrontal cortex during traumatic provocation in patients with PTSD (Hull,
2002). Shin et al., (2004) directly tested the relationship between the amygdala and 
medial prefrontal regions during provocation and found that amygdala activation and 
medial frontal gyrus activation were negatively correlated in nurses and combat veterans 
(Shin et al., 2004). CAPS scores could significantly predict these patterns o f activation 
even after controlling for depression. Studies have found abnormal frontal slow-wave 
activity using EITP during assimilation of new information in working memory in patients 
with PTSD (Galletly et al., 2001). PET studies (Clark et al., 2003) show that unlike
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Controls, PTSD patients do not have left activation of the inferior parietal lobe and the 
dorsolateral prefrontal eortex during working memory updating, suggesting that PTSD 
patients do not use symbolic representation. There was however, inereased activation of 
the posterolateral aspeet o f the superior parietal lobe indicating more relianee on 
visuospatial coding (Clark et al., 2003). An interesting replieated finding o f note, is the 
deactivation of Broca’s area (Raueh et al., 1996; Shin et al., 1997). The deaetivation of 
Broea’s area may contribute to the diffieulty people with a history of trauma have in 
restrueturing their experience (Hull, 2002). Overall, the most robust physiological 
finding associated with PTSD is hypoactivity in the pre-frontal cortex.
Neurocognitive Function. Over 50% of sexually abused patients experience 
memory intrusions and memory impairment (Craine, Henson, Colliver, & MacLean, 
1988). Typical complaints from trauma survivors are problems with memory, learning, 
attention, and coneentration (Palmer et al., 1999). Clinicians have noted deficits in 
planning, organization, and judgment (Palmer, Frantz, and Armsworth, 1999). Severity 
of PTSD has been correlated with overall inconsisteney of memory (Zoellner, Sacks, & 
Foa, 2001). This is typically characterized by an inability to remember parts of the 
trauma (autobiographical). For example, sixty-four pereent o f raped females have had 
some amnesia (Herman & Schatzow, 1987). Archibald and Tuddenham (1965) 
documented memory loss regarding combat in WWII veterans.
Studies have found working memory, explicit general memory, and to a smaller 
extent implieit memory deficits in survivors of trauma (Jenkins, Langlais, Delis, & 
Cohen, 1998; McNally et al., 1998; Williams, Bremner et al., 1995). Severe 
autobiographical memory deficits (amnesia) in rape survivors have been demonstrated by
43
Williams (1995) who contacted women that had been in the hospital 17 years prior to 
questioning for sexual abuse. O f these 129 women 38% did not recall the incident.
Other studies regarding general explicit memory have found greater disturbance in those 
people with PTSD than those participants without PTSD (Jenkins, Langlais, Delis & 
Cohen, 1998). Utilizing the California Verbal Learning Test, PTSD patients had 
significant impairment in long-delay recall and short- delay recall compared to those 
trauma survivors without PTSD or controls. The deficits found in explicit memory were 
not due to differences in learning strategy as measured by the semantic and serial 
clustering indices. Since the performance differences could not be accounted for by 
learning strategies, IQ differences, or presence of substance abuse, Jenkins, Langlais, 
Delis & Cohen suggested that the differences in explicit memory were due to the 
presence o f PTSD. Vasterling, Brailey, and Sutker (2000) found that veterans with PTSD 
were impaired on measures of verbal learning, but not other measures of dorsolateral 
prefrontal and medial temporal functioning as compared to veterans without PTSD 
(Vasterling, Brailey & Sutker, 2000).
Using the Wechsler Memory Scale (Russel, 1978) and the verbal Selective 
Reminding Test (vSRT; Hannay & Levin, 1985) Bremner et al., (1993, 1995) found 
deficits in verbal declarative memory in combat veterans with PTSD and in PTSD 
patients with childhood abuse. The amount of impairment was associated with the 
severity of abuse. Yehuda, Golier, Halligan and Harvey (2004) have shown that 
Holocaust survivors with PTSD exhibited verbal learning deficits after controlling for IQ 
on the CVLT. The memory differences are due to total learning and may reflect a limit in 
memory capacity. Other studies like the one by Neylan et al., (2004) found no relation
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between hippoeampal n-acetylaspartate (NAA) levels and memory using the CVLT and 
portions o f the WMS-III. They also found no difference in cognitive function between 
the veterans with PTSD and those without. The treatment criteria in this study were very 
stringent and ruled out any patient that had another comborbid disorder in the past three 
months, substance abuse in the past five years, any patients with head trauma or those 
that had taken benzodiazepines or antipsychotic medication in the last 6 weeks (Neylan et 
al., 2004). In conclusion, it appears that individuals with PTSD experience deficits in 
verbal explieit memory.
Being that the physiological findings regarding the prefrontal eortex in PTSD are 
the most robust, we would expect to see consistent results in regards to the cognitive tests 
for this area. Tests for the prefrontal cortex include measures o f attention, planning, set 
shifting, and working memory. Victims of intimate partner violence, regardless of PTSD 
status, performed poorly on tasks of sustained attention, working memory, and response 
inhibition (Stein, Kennedy, Twamley, 2002). Felmingham, Bryant and Kendall (2002) 
and Akari et al., (2005) have found reduced latencies in seareh time during the oddball 
task in individuals with PTSD, suggesting that individuals with PTSD may have 
increased difficulty in discriminating and attending to particular stimuli. Similarly, 
Semple et al., (1996) noted that combat veterans had more false alarms on the auditory 
eontinuous performance task. Golier et al., (1997) did not find any difference in 
performance on the CPT in individuals with PTSD. It is unclear whether individuals with 
PTSD experienee more difficulties with attention than individuals not exposed to trauma. 
These studies suggest that a trauma history is associated with poorer performance on 
attention measures.
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Gilbertson, Gurvits, Lasko, Orr and Pitman (2001) have noted impairments in 
executive function in combat veterans with PTSD. Specifically, the PTSD group had 
significant impairments on the digit span of the WAIS-R, Trail Making Test B, and 
WCST categories, perseverative responses and noperseverative errors. Sutker et al., 
(1991) also identified deficits in executive function on the Categories Test and the 
WCST. On the other hand, Vasterling et al., (1998) did not find any differences in the 
WCST, digit span of the WAIS-R or on the Stroop in a sample of veterans. Therefore, 
results of cognitive testing for prefrontal functioning are not as convincing as the 
functional imaging data, particularly in the executive function domain.
In addition to the subjective emotional reports and physiological arousal identified 
in individuals with PTSD, there have recently been some empirical studies on emotional 
processes. There have been deficits associated with the congruence of facial expression 
and self-report o f emotion in women who had PTSD after being sexually assaulted 
(Wagner, Roemer, Orsillo, Litz, 2003). Bremner et al., (2003) performed PET while 
asking patients to remember neutral or traumatic word pairs. Deeply encoded neutral 
words were recalled better than deeply encoded negative words, which were both better 
than shallowly encoded words. This was the same pattern for people with PTSD and 
controls. The pattern of activation only differed between the two groups when retrieving 
emotionally valenced words. Michael, Ehlers and Halligan (2005) found that assault 
survivors with PTSD had increased priming for trauma-related words compared to assault 
survivors without PTSD. There is increasing evidence to suggest that trauma survivors 
experience cognitive deficits in emotional processing.
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Exposure to a traumatic event may cause enough stress to an individual to 
precipitate behavioral and affective changes. The neurochemical changes can result in 
changes to the brain structures and function. While not consistently found, evidence 
suggests that individuals with PTSD exhibit decreases in hippocampal volume. There is 
also neuronal loss in the anterior cingulate resulting in decreased volume. Functionally, 
the amygdala is hyperresponsive, while the medial prefrontal cortex is hypoactive. The 
neurocognitive deficits most commonly found in PTSD are problems with explicit 
memory. These findings provide support for the proposition that stress and trauma cause 
alterations to brain structure and function.
Comorbid Schizophrenia and PTSD
The following section will be a discussion of comorbid schizophrenia and PTSD. 
It will include information regarding prevalence and diagnosis, followed by a discussion 
of the impact that trauma may have on those with mental illness and a review of two 
models proposed to explain the high rates of comorbidity and the increase o f psychiatric 
symptoms between the two disorders. There have not been any studies to examine the 
structural, functional or neurocognitive findings associated with PTSD in individuals 
with schizophrenia, so there will be a discussion of three potential models to address the 
pattern of neurocognitive deficits associated with comorbid schizophrenia and PTSD.
Prevalence
Rates o f  trauma. Studies suggest that the rate of traumatic events in individuals 
with severe mental illnesses is higher than in the general population. For example, 43% 
to 81% of individuals with severe mental illness have been exposed to either physical or 
sexual interpersonal violence (Hutchings & Dutton, 1993; Jacobsen, 1989; Lipschitz et
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al., 1996). Another large multi-site study (n=782) of victimization in those with severe 
mental illness found 87% of the sample had been vietimized in some way (Goodman et 
al., 2001). Women were mueh more likely to have been sexually assaulted, while men 
were more likely to have experienced physieal assault (Goodman et al., 2001). 
Childhood abuse has been reported in 34% to 53% of individuals with severe mental 
illness (Craine, Henson, Colliver & MaeLean, 1988; Greenfield et al., 1994; Mueser et 
al., 1998; Ross et al., 1994). As doeumented in these studies, the rates o f traumatic 
events in individuals with sehizophrenia are higher than in the general population.
Reeent victimization is also more prevalent in people with severe mental illness 
than in the general population. Seventy-nine pereent of individuals with severe mental 
illness have been vietimized within the last year (Caseardi, Mueser, DeGirolomo, & 
Murrin,1996) and 33% of mentally ill homeless women had been sexually or physieally 
assaulted within the last 30 days (Goodman, Dutton, & Harris, 1997). As noted above, 
those individuals who are homeless and have a severe mental illness have even higher 
rates o f interpersonal violenee than non-homeless individuals with severe mental illness. 
Goodman et al. (1995) and Davies-Netzley et al. (1996) found that between 77% and 
97% of homeless individuals with severe mental illness experieneed interpersonal 
violenee. Another subset o f individuals that may be partieularly suseeptible to traumatic 
events is those individuals with sehizophrenia who also abuse substanees (Gearon, 
Kaltman, Brown & Bellaek, 2003).
Many individuals with severe mental illness will also be exposed to multiple 
traumas (Mueser, Goodman, & Trumbetta, 1998). Goodman et al. (2001) reported that 
revictimization rates were partieularly high with 67% of the sample reporting abuse in
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childhood and adulthood. These revictimization statistics may be accounted for by the 
fact that there is an increased rate of multiple traumatization in the general population 
when individuals were abused as children or with people who have been sexually 
assaulted (Classen, Palesh, Aggaral, 2005; Vrana & Lauterbach, 1994). Briere et al. 
(1997) replicated the relationship between childhood sexual abuse and adult victimization 
in a sample o f psychiatric inpatients with severe mental illness. They did not find the 
same relationship in these patients when the childhood abuse was physical abuse rather 
than sexual abuse. In a sample of substance abusing women with schizophrenia the 
average number of traumatic events reported was eight (Gearon, Kaltman, Brown & 
Bellaek, 2003). As might be expected, revictimization is associated with greater PTSD 
symptom severity (Follette et al., 1996).
As with non-mentally ill patients, different types o f trauma are associated with 
different rates of PTSD. A regression analysis of female psychiatric inpatients with 
severe mental illness indicated that both child and adult assaults were associated with 
psychiatric difficulties, with childhood sexual abuse was the most powerful predictor of 
psychiatric difficulties even after controlling for demographic variables (Briere et al., 
1997). Gearon et al., (2003) found that sexual abuse was the type of trauma associated 
with the highest levels of PTSD symptoms. Similarly, in a study by Mueser et al., (1998) 
childhood sexual assault was the strongest predictor of PTSD for both men and women, 
but women who were physically attacked and witnessed a killing or severe injury in 
childhood were also prone to develop PTSD. In adulthood, women who were sexually 
assaulted or witnessed a killing or serious injury were prone to PTSD, while there was no 
specific trauma type for men that was most likely to cause PTSD (Mueser et al., 1998).
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In conclusion, the number of traumas experienced and being sexually abused as a child 
are significant predictors of PTSD and are also predictive of adult victimization in 
individuals with severe mental illness (Mueser et al., 1998).
Rates o f  PTSD. As might be expected, the prevalence rates for diagnosis of PTSD 
are also much higher in individuals with severe mental illness. Six studies assessing 
PTSD in individuals with severe mental illness found 29% to 43% of their sample 
qualified for diagnosis of PTSD, which is in sharp contrast to a rate 8% as observed in the 
general population (Mueser, Salyers, Rosenberg, Ford, Fox, & Carty, 2001). Another 
study documented a diagnosis of PTSD in 66% of their sample of individuals with severe 
mental illness (Craine, Henson, Colliver and MacLean, 1988). None of these participants 
had received treatment related to their trauma symptoms. Mueser et al. (1998) found 
43% of the individuals with schizophrenia in their sample qualified for diagnosis of 
PTSD and had similarly not received treatment for trauma symptoms.
Individuals with schizophrenia who also have another comorbid disorder, such as 
substance abuse, may be particularly susceptible to developing PTSD after experiencing 
trauma. In particular, in individuals with comorbid substance abuse and schizophrenia, 
Gearon et al. (2003) found that 46% of their sample of women with comorbid substance 
abuse and schizophrenia had PTSD. Once again, 46% is much higher than the rate of 
PTSD in the general population (8%) or the rate of PTSD in individuals with 
schizophrenia (around 30%) or the rate of PTSD in substance abusing women (30%).
Despite the high prevalence of trauma and subsequent PTSD in those with severe 
mental illness, PTSD is still widely under-diagnosed in this population (Craine, Henson, 
Colliver, & MacLean, 1988). In a review of six studies assessing rates of PTSD in
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individuals with severe mental illness, only 5% of those patients that qualified for a 
diagnosis of PTSD actually had a diagnosis of PTSD in their chart (Mueser et ah, 2001). 
One study found that of those individuals with schizophrenia that had been traumatized 
38% had not diseussed it with a eounselor, 36% had never told a friend or family member 
and 28% had told no one other than the interviewer (Resniek, Bond & Mueser, 2003). 
Two other studies deseribed above doeumented rates of untreated PTSD in 66% and 43% 
of their samples (Mueser et ah, 1998; Craine, Henson, Colliver, & Maclean). Thus, 
identifying those patients with a history of prior trauma is erucial in identifying those at 
risk for re-traumatization, as well as, identifying those at risk for developing PTSD.
Impact o f  Trauma on Schizophrenia Outcomes. Research has clearly 
demonstrated the negative impaet of trauma on mental illness. The presenee of trauma in 
individuals with sehizophrenia is eorrelated with increased psychiatric disturbance and 
poorer funetional and treatment outeomes. Craine, Henson, Colliver and MaeLean 
(1988) found that individuals with severe mental illness who had been sexually abused 
exhibited signifieantly more symptoms eommonly linked to sexual abuse (e.g. 
eompulsive sex behavior, erying, low energy) than in those without a history of abuse 
suggesting that trauma causes additional symptoms that are distinet from the symptoms 
assoeiated with ehronic illness alone and are more refleetive of PTSD symptoms. Read 
and Ross (2002) also noted that individuals with severe mental illness and a history of 
childhood abuse had more general psyehiatrie symptoms. In individuals who have 
schizophrenia and comorbid substance abuse, revictimization was associated with greater 
PTSD symptom severity as measured by the Clinieian Administered PTSD Scale (CAPS) 
(Resnick, Bond & Mueser, 2003). Resniek, Bond and Mueser (2003) found that in
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individuals with schizophrenia, hyperarousal, emotional discomfort and avoidance as 
measured by the CAPS were highly correlated with the presence of a traumatic event. 
There was a consistent relationship between the severity of trauma and severity o f PTSD 
symptoms among women. The avoidance subscale, in particular, was significantly 
correlated with the positive symptoms on the Positive and Negative Syndrome Scale 
(PANSS) suggesting that the avoidance o f trauma-related stimuli may exacerbate positive 
symptoms of schizophrenia.
History o f childhood abuse also appears to increase positive symptoms typically 
associated with schizophrenia in those who are not diagnosed with the disorder. In 
accordance, Ross, Anderson and Clark (1994) found more positive symptoms of 
schizophrenia in those with a history of childhood abuse. In a college sample without 
schizophrenia, Ross and Joshi (1992) found that the number of Schneiderian symptoms 
endorsed was significantly correlated with a history of abuse, the number o f perpetrators 
and the number or types of sexual abuse experienced. Mullen et al., (1993) found that 
women who had experienced any type of sexual abuse were 5.4 times more likely to have 
been a psychiatric inpatient. These numbers increased to 16.8 when penetration 
occurred. Childhood sexual abuse survivors also had significantly higher scores on the 
neuroticism scale on the NEO Five Factor Inventory (Costa & McCrae, 1989). These 
findings suggest that childhood trauma can predict an increase in schizophrenia-like 
psychiatric symptoms regardless of prior psychiatric history.
A trauma history also suggests poorer functional and treatment outcomes in 
individuals with schizophrenia. Lysaker, Meyer, Evans, Clements, and Marks (2001) 
found that individuals with schizophrenia who were also survivors of childhood abuse
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had significantly poorer scores on instrumental role and intrapsyehie foundations 
subscales of the Quality o f Life Scale (Heinrichs, Hanlon, & Carpenter, 1984) reflecting 
impairments in the quality of their relationships. Individuals with schizophrenia and a 
trauma history are more likely to have comorbid substance abuse and to be homeless 
(Goodman, Rosenberg, Mueser & Drake, 1997: Mueser, Goodman, Trumbetta, 
Rosenberg, Osher, Vidaver, Auciello, & Toy, 1998). Individuals who have experienced 
childhood abuse and also have schizophrenia are more likely to attempt suicide, receive 
more medication, have longer hospitalizations, and have an earlier first admission for 
psychiatric treatment (Read & Ross, 2003). Recent assault also contributes to recent 
homelessness, alcohol and drug use, more hospitalizations in the last year, and an earlier 
first age of psychiatric hospitalization (Goodman et al., 2001). Rates of PTSD were 
dramatically higher in forensic patients with paranoid schizophrenia (52%) versus 29% in 
a non-offender population of patients with paranoid schizophrenia (Sarkar, Mezey,
Cohen, Singh, & Olumorot, (2005). Despite the implications o f trauma for those 
individuals with schizophrenia, research regarding traumatic events in the lives of those 
with schizophrenia has been sparse and PTSD remains under-diagnosed in schizophrenia 
(Sanislow & Carson, 2001).
Diagnosing PTSD in Schizophrenia. One factor that contributes to the under­
diagnosis o f PTSD and schizophrenia, possibly limiting research attempts thus far, is the 
practical question of accurately assessing PTSD symptoms in individuals with severe 
mental illnesses. Some have suggested that because the nature o f schizophrenia involves 
distortions of reality, it is unclear whether the memory of a traumatic event is as reliable 
as an individual without schizophrenia. A study examining the reliability of child abuse
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reports by Fergusson, Horwood and Woodward (2000) using a large (N=1265) birth 
cohort found that reports of abuse in controls was relatively unstable with a test-retest 
kappa value of .45. The unstability o f reporting reflected an underreporting o f traumatic 
events. Fergusson, Horwood, and Woodward (2000) also found that inconsistencies in 
reporting were not related to psychiatric state, suggesting that the severely mentally ill 
can be reliably evaluated. Other studies have found fair to moderate test-retest reliability 
in patients with and without severe mental illness (Goodman, Cocoran, Turner, Yuan, & 
Green, 1998, Goodman, et al., 1999). Goodman et al. (1999) demonstrated that 
individuals with severe mental illness had similar percentages for the consistency of self- 
reported trauma (86% in individuals with severe mental illness versus 85% in the student 
sample for adult physical abuse and 97% versus 80% for childhood abuse) over a two 
week period as a student sample. The self-report of PTSD symptoms in patients with 
severe mental illness also had a good reliability with a test-retest correlation o f .81 at two 
weeks (Goodman, 1999). Convergent validity o f PTSD diagnosis by interview and self- 
report measures using strict PTSD criteria was k  = .90 (Mueser et al., in press). Test 
retest of the CAPS and PTSD checklist (PCL; a measure o f PTSD symptoms) were also 
significant at .77 and .66 indicating high reliability for both self-report and interview 
assessment o f PTSD symptoms. Mueser et al. (2001) found a mean inter-rater reliability 
of .96 between the CAPS and the Trauma History Questionnaire (a self-report 
questionnaire asking the individual to state if  they had experienced each type of trauma 
and when the trauma occurred) in individuals with severe mental illness suggesting that 
measurements used in other samples could reliably be used with individuals who have 
severe mental illnesses. Internal consistency was also high at .94 (baseline) and .95
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(follow-up). Kappa values were at approximately .60 for the most prevalent types of 
trauma indicating moderate to high test-retest reliability of trauma reports and PTSD 
diagnosis. The kappa values were lower at .36 and .43 for life-threatening illness and the 
death o f a friend or relative.
Models Proposed to Explain Comorbidity Between Schizophrenia and PTSD. 
There are two theories proposed to account for the high comorbidity between 
schizophrenia and PTSD. The first of these is the traumagenic neurodevelopmental 
model (Read, Perry, Moskowitz and Connolly, 2001). The traumagenic 
neurodevelopmental model suggests that some individuals with schizophrenia may have 
had an early traumatic event that could trigger the onset of schizophrenia symptoms and 
may cause or contribute to the neurodevelopmental abnormalities seen in schizophrenia. 
Or, put another way, they would posit that schizophrenia is a trauma based disorder. As 
support for their model Read, Perry, Moskowitz and Connolly (2001) have cited the 
similarities between the effects of traumatic events on the brain and the biological 
abnormalities associated with schizophrenia. In particular, these biological abnormalities 
include over-reactivity of the hypothalamic-pituitary-adrenal (HP A) axis, 
neurotransmitter abnormalities, and structural changes to the brain.
The second major area of support delineated by the authors for the traumagenic 
neurodevelopmental model comes from studies of the environmental influence in 
schizophrenia. For example, environmental influences like family hostility (Tairier & 
Turpin, 1992), adoptive studies (Tienari, 1991) and other environmental stressors in 
utero. Read et al. (2001) reported that adoptive families had 7 times more explanatory 
power than genetics in predicting who would develop schizophrenia. Furthermore
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children living in an institution are 2.7 times more likely to be diagnosed with 
schizophrenia as adults than children living at home (Canon et al., 2001). Other 
environmental stressors like traumatic brain injury have also been linked with 
schizophrenia (Malaspina et al., 2001). Malaspina documented that 17% of adults 
diagnosed with schizophrenia have had a traumatic brain injury. There is some evidence 
that would be contrary to the traumagenic model posited by Read, Perry, Moskowitz, and 
Connolly (2001). For example, Rosenberg et al. (2001) suggested that individuals with 
severe mental illness report higher rates of trauma in adulthood rather than in childhood. 
This would remove the possibility of schizophrenia being caused by a traumatic event in 
the individuals traumatized in adulthood after the emergence o f schizophrenia.
The other model suggests that there is an interaction between PTSD and 
schizophrenia such that individuals with schizophrenia may be more susceptible to 
traumatic events or to the psychological effects o f trauma because o f the deficits 
associated with schizophrenia (Mueser, Rosenber, Goodman & Trumbetta, 2002). For 
example, people with schizophrenia are more likely to be homeless or to use substances 
than the general population and both o f these variables are associated with increased rates 
o f traumatic exposure (Goodman, Rosenberg, Mueser & Drake, 1997; Mueser, Goodman, 
Trumbetta, Rosenberg, Osher, Vidaver, Auciello, & Foy, 1998). Research has also 
documented that individuals with a history o f childhood sexual trauma have poorer 
vocational performance (Lysaker, Nees, Lancaster, & Davis, 2004). On the other hand, 
mental illness may also be a predictor of who will develop PTSD, such that an individual 
may be more likely to develop PTSD after a traumatic event if  they are exposed to a 
traumatic event. Research citing increased rates of developing PTSD in people with a
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history of psychiatric history would support this assertion (Breslau et ah, 1995). The 
interaetive model also suggests that PTSD can influence schizophrenia symptoms. This 
is illustrated by the increase of more positive symptoms of sehizophrenia and more 
general psyehopathology assoeiated with PTSD in individuals with sehizophrenia 
(Sautter et ah, 1999). In the interaetive model proposed by Mueser et ah, PTSD ean 
direetly and indirectly affect symptom severity, risk of relapse and use of services. 
“Direct pathways could be avoidanee of trauma related stimuli, distress related to re- 
experieneing the trauma, and overarousal” (Mueser et ah, 2002). For example, Mueser et 
ah (2002) cite that the avoidance of trauma related stimuli and distress related to re- 
experieneing the trauma in PTSD could result in increased social isolation for individuals 
with schizophrenia and increased vulnerability to psychotic symptoms. Indirect 
influences include things like difficulty in relationships or an increased likelihood of 
utilizing substances, which would increase the risk of experiencing a traumatic event.
For a graphic description of the interactive model see Figure 2. Individuals with 
schizophrenia or PTSD may have difficulty interacting with and understanding their 
environment, they may not be as cautious because they have a foreshortened sense of the 
future, are utilizing substances, or do not possess the safety of a shelter (i.e., homeless). 
They may also be so focused on specific triggers or avoidance of those triggers that they 
miss other important cues in their environment making them more susceptible to trauma 
(Mueser, Rosenberg, Goodman, & Trumbetta, 2002). Furthermore, people with severe 
mental illness have less coping resources to deal with the effects of trauma (Seedat et al., 
2003).
57
Neurocognitive Deficits in Comorbid Schizophrenia and PTSD. Despite the 
aecumulating evidenee for neurobiological dysfunction in both sehizophrenia and PTSD, 
there is a dearth of studies specifically examining the nature and severity of brain 
structure and function abnormalities in those individuals with these comorbid diagnoses. 
One study conducted by Lysaker, Meyer, Evans, & Marks (2001) examined 
neurocognitive impairment associated with a childhood history of sexual abuse in 
individuals with schizophrenia. This study identified deficits in working memory and 
information processing, suggesting that neurocognitive deficits are likely found in the 
comorbid presentation of schizophrenia and PTSD and that these deficits would be more 
than those assoeiated with purely a history of childhood sexual abuse.
Figure 2: Interactive model o f trauma, PTSD, and severe mental illness. PTSD is 
hypothesized to worsen the severity and course of serious mental illness through the 
direct effects of PTSD symptoms and indirectly through the effect o f PTSD on substance 
abuse, retraumatization, and a poor working alliance with clinicians, leading to receipt of 
fewer preventative illness management services. Reprinted from Mueser et al. (2002).
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There are other non-specific studies suggesting that extreme stressors may 
provide a viable mechanism for neural damage in patients diagnosed with schizophrenia. 
For example, Walker and Diforio (1997) suggested that a smaller hippocampus in first- 
episode schizophrenia could also be related to prior exposure to stress. They found that 
individuals with schizophrenia had elevated cortisol at baseline and after pharmacological 
challenges, suggesting that individuals with schizophrenia had been previously been 
exposed to stressful situations. More recently, Corcoran et al. (2003) have suggested that
because “  the biological effects of stress are mediated by the hypothalamic-pituitary-
adrenal (HP A) axis, which governs the release of steroids, including cortisol.... the HP A 
axis and its interaction with intervening life events are apt candidates for study” (p. 671). 
Thus, the exploration of brain function in those with comorbid PTSD is an important area 
of investigation.
As previously suggested, both schizophrenia and PTSD are associated with 
unique patterns o f neurocognitive deficits. Those suggesting that there is a single 
etiology for both PTSD and schizophrenia state that both disorders have the same 
physiological attributes and subsequent neurocognitive deficits. In addition, this model 
suggests that the neurocognitive deficits are present by the first-episode of schizophrenia, 
providing some evidence to suggest that the neurocognitive deficits associated with 
schizophrenia could potentially have been caused by a traumatic event. Walker and 
DiForio (1997) provide some evidence for pre-existing HP A hyperactivation in 
individuals with schizophrenia. Walker and DiForio found that individuals with 
schizophrenia already had a negative response to dexamethasone suppression test (DST) 
suggesting prior exposure to traumatic events. However, a close examination o f the
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literature does not provide strong support for the idea that the same pattern of 
neurobiological and neurocognitive dysfunction exists in both in schizophrenia and 
PTSD. Specific areas of improper function common to both disorders include hyper­
reactivity o f the hypothalamic-pituitary-adrenal axis (HP A), improper function of 
neurotransmittors, and hippocampal volume and function (Seedat et al., 2003). Contrary 
to this model, however, is evidence to suggest that schizophrenia does have some unique 
impairments not seen in PTSD (e.g., motor function and smell deficits).
To arrive at a prediction regarding the neurocognitive performance associated 
with comorbid schizophrenia and PTSD, the results of the neurocognitive findings for 
each disorder will be summarized. In schizophrenia, there have been consistent deficits 
across all domains of neurocognitive function. In PTSD, research has been more 
inconsistent with regard to the corresponding neurocognitive function. There is some 
support for the idea that attention, executive function, working memory, and verbal 
memory are slightly impaired.
The resulting predictions regarding the neurocognitive of the comorbid group are 
a combination o f the effects for each group, with some multiplicative effect of 
impairment for each domain. Therefore, it may be predicted that the comorbid group will 
not have any additional deficits than those occurring in schizophrenia alone on motor 
function. A synergistic effect would also not be predicted in regards to visual memory as 
there is not literature to suggest these impairments in PTSD. On the other hand, both 
groups individually have been associated with impairments across the remainder of the 
domains and so it would be predicted that the comorbid group will exhibit a level of 
impairment more severe than the impairment associated with either disorder alone, and
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impairment more severe than reflecting the addition of the corresponding deficits for each 
group, supporting a synergistic model.
However, because no studies have examined the neurocognitive deficits 
associated with eomorbid schizophrenia and PTSD, the pattern o f defieits suggested for 
those with schizophrenia PTSD comorbidity remains speculative. Furthermore, the 
models previously reviewed that have attempted to explain the high prevalence of 
sehizophrenia PTSD comorbidity do not have direct application to neurobiological 
dysfunction, and so provide little guidance in generating hypotheses in this area. As the 
current models explaining high schizophrenia and PTSD comorbidity do not consider the 
interacting effects o f neurocognitive function, three alternative models are proposed.
The first model postulates that the etiology of PTSD and schizophrenia are the 
same so there would be no unique deficits to either disorder, they would only vary in 
severity. The other two models, the additive model and the synergistic model, suggest 
that the etiology of PTSD and schizophrenia are different. The additive model suggests 
that there will be some unique deficits associated with each disorder and that individuals 
with comorbid PTSD and schizophrenia will perform more poorly than those with either 
PTSD or schizophrenia alone. In fact, the performance deficit associated with comorbid 
PTSD and schizophrenia would be a pooled total (sum) of the defied associated with 
PTSD and schizophrenia. While the final model, the synergistie model, also assumes 
different etiology of the two disorders, it asserts that the total deficits associated with 
comorbid PTSD and schizophrenia are not just the combined total o f the deficits 
associated with either disorder. Rather, the total defieits in schizophrenia PTSD 
comorbidity are multiplieative or synergystic. This study will evaluate these models by
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comparing the pattern and extent of neuropsychological deficits associated with each 
disorder separately and when the disorders are comorbid.
The additive and synergistic models pre-suppose that schizophrenia and PTSD 
have different etiologies. Additionally, it would be suggested that the physiological 
processes underlying each disorder might contribute to the neurocognitive effects of the 
comorbid presentation. In particular, research has cited that noradrenergic and 
corticotrophin-releasing hormone systems in PTSD can augment the stress response and 
contribute to schizophrenia (Seedat et al., 2003). Conversely, long-term antipsychotic 
usage associated with schizophrenia can cause dopaminergic hypofunction, decreasing 
the firing rate in the locus coreleus and enhancing the noradrenergic activity seen in 
PTSD (Seedat et al., 2003). These are only two possible explanations of the complex 
interaction of how the physiological process associated with each disorder may interact to 
create increased cognitive impairment.
Hypotheses
The main purpose of this study was to determine the neurocognitive profile of 
comorbid schizophrenia and PTSD. The results of this study can further clarify whether 
PTSD and schizophrenia have the same underlying etiology or different etiologies, while 
at the same time providing support for a model to demonstrate if  and how the two 
disorders influence one another. The answers to these questions will be important in both 
the treatment and prevention of PTSD and comorbid schizophrenia. Currently, trauma 
history and PTSD are largely ignored in treating individuals with schizophrenia. Also, 
psychological and pharmacological treatment for schizophrenia and PTSD vary
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considerably suggesting that proper treatment of comorbid PTSD can potentially mitigate 
many of the serious adverse effects seen in schizophrenia.
To answer these questions a four-group design was used: controls (C), a group of 
individuals with PTSD (PTSD), a group of individuals with schizophrenia (SZ), and 
individuals that have comorbid schizophrenia and PTSD (SZP). All groups were tested 
on a comprehensive neuropsychological battery, which assessed all cognitive domains. 
Comprehensive interviews were also conducted to evaluate psychiatric symptoms and 
diagnoses.
I. On schizophrenia symptom measures (SANS, SAPS, and BPRS) the SZ 
groups will score significantly higher than the PTSD group. In regard to 
the SZ and SZP groups, it is predicted that the SZP group will score higher 
on the SAPS, the measure o f positive symptoms of schizophrenia, and the 
BPRS, a measure of more general psychiatric symptoms. It is predicted 
that the SZ group will score higher on the SANS, a measure of negative 
symptoms. It is hypothesized that the two groups with PTSD will score 
higher than the SZ control group on other symptom measures (CDS and 
PCL).
II. On the motor domain measures, there should be no difference between the 
SZ and SZP groups. Additionally, the PTSD and Control groups will 
score significantly higher or exhibit no impairment.
III. For this hypothesis it was predicted that:
1. On measures of neurocognitive impairment including explicit memory 
(verbal and spatial), working memory (verbal and spatial), emotional
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memory, executive function and attention, all three clinical groups would 
exhibit impaired performance relative to controls.
2. The comorbid group would have significantly more impairment than either 
the PTSD or SZ group.
3. The level of impairment is more than the deficits associated with either 
schizophrenia or PTSD combined supporting a synergistic model of 
neurocognitive deficits.
IV. The SZ and SZP group will have significantly lower scores on the WAIS- 
III subscales: Information, Vocabulary and Block Design.
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CHAPTER 3 
METHODOLOGY
Participants
The participants in the study were recruited from the community and the 
University of Nevada, Las Vegas. For the most part, the individuals with schizophrenia 
were clients at Mojave Mental Health, a day treatment program for individuals with 
severe mental illnesses, controls were obtained from the community, and PTSD 
participants were recruited from the psychology subject pool. Each group had some 
participants who were recruited through one of the other methods (i.e., some Control 
participants recruited from the community were included in the PTSD group). The 
Control group had 26 participants. The PTSD group had 21 participants. The SZ control 
group had 26 participants and the SZP group had 21 participants. These numbers reflect 
fewer participants than completed the study in order to more closely match the groups on 
age and education. Participants ranged between 18 and 60 years old.
Participants were compensated for participation monetarily or with credits to 
fulfill the undergraduate research requirement. Undergraduate students received one 
credit for each hour o f their participation, with a minimum of five credits. Participants 
from the community received $5 per hour with a $30 bonus for completing the study.
For the undergraduate students who were not able to continue in the study based on 
eligibility requirements they were still given the five research credits. This was based on
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the fact that the student had committed to a five hour block of time when signing up for 
the study. Participant payments were somewhat variable and ranged from $60 to $100 
dollars. The reason for this variability was based on the amount o f time it took for the 
individual to complete the testing. There was a great deal o f variability in the length of 
time necessary to complete the tests based on the number o f breaks necessary, the actual 
response time for individual items, and in the length of the structured interview. 
Participants from the community who were unable to participate based on eligibility 
requirements were paid for the time they had spent with the interviewer. This was 
between $2.50 and $10.00 with the majority of the people receiving $2.50. Testing took 
between four and ten hours based on the individual factors mentioned above and was 
completed in as many sessions as necessary based on the needs of the participant.
All participants gave informed consent prior to participating in the study. 
Exclusionary criteria applicable to all of the groups included a history of a head injury, 
seizures, mental retardation, if  English was not their primary language or they were 
unable to provide consent. Individuals were included in the Control group if they did not 
have any psychiatric diagnoses as determined by the Structured Clinical Interview for 
DSM-IV (SCID). However, participants were included in the Control group if  they had a 
discrete psychiatric episode that had resolved more than one year ago (e.g., depression). 
Participants were also excluded from the Control group if they had been exposed to a 
traumatic event and experienced subthreshold symptoms of PTSD.
Participants could only be included in the PTSD group if they had a lifetime 
diagnosis of PTSD as determined by the SCID. For the SZ group, individuals with a 
diagnosis of schizophrenia as assessed by the SCID and confirmed with medical records
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and they did not have subthreshold levels o f PTSD. Individuals in the comorbid 
schizophrenia PTSD group had a diagnosis of both schizophrenia and a lifetime diagnosis 
o f PTSD. Individuals could not have a current substance dependence diagnosis in any of 
the three clinical groups. Individuals in the three clinical groups were not excluded on 
the basis o f other psychiatric disturbances. Other psychiatric symptoms were not an 
exclusion from any o f the three clinical groups. This more accurately reflected the 
general population o f those individuals with schizophrenia and PTSD. Additionally, it 
was expected that random assignment to either one of the schizophrenia groups would 
factor out the effects o f other symptoms.
Procedure
Participants were recruited through an advertisement in the psychology subject 
pool, after a brief description provided by one of their mental health workers or by one of 
the researchers for the study. Individuals who were interested in participating in the 
current study provided written informed consent prior to completion of any of the study 
procedures. Appendix I contains the four informed consent forms used in the study.
There was an informed consent form for the Control participants recruited from the 
community, for the Control participants recruited from the psychology subject pool, for 
the PTSD participants recruited from the psychology subject pool, and the schizophrenia 
subjects recruited from the community. Study procedures were usually completed over 
multiple sessions, however, many o f the PTSD participants required only one session 
because the total assessment time for this group was usually 4 hours. The demographic 
and symptom measures were always given first to determine eligibility for the study. 
Control subjects were not given the clinical interview to determine SANS, SAPS, CDS or
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BPRS scores based on the fact that these assessments are designed for individuals with 
clinical populations.
Neuropsychological testing and self-report measures were administered as the 
second component in the study. The neuropsychological tests were administered in a 
random fashion. This was done for a variety o f reasons. The first priority was to 
accommodate the needs and comfort of the participants. For example, sometimes the 
participant would need to switch the type of tasks they were doing in order to improve 
concentration or decrease frustration. At other times, the participant would need to leave 
at a specific time limiting the type of task to be completed in that time frame. At other 
times, there were constraints on the situation. For example, testing was concurrently 
occurring in three different locations by multiple examiners and certain materials were 
only available in specific rooms. Finally, random administration o f the tests controlled 
for potential carryover or practice effects. Practice effects were o f particular importance 
on the memory measures. The CVLT, EVLT and Biber all had the same administration 
format and so following exposure to the first memory test, performance could have 
potentially been facilitated on subsequent memory tests. There were some exceptions to 
the randomization of neuropsychological tests. During the intervals for each of the 
memory tasks, individuals were not given any other memory task. Furthermore, 
individuals could not be given a task during an interval for a memory test that was within 
the same modality (e.g.. Block Design could not be administered in the delay o f the Biber 
Figure Learning Test). Detailed descriptions o f all tests and testing procedures are 
provided in the measures section. Furthermore, in the measures section, the tests will be 
grouped to illustrate how the cognitive domains were identified. Each test was
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administered according to standardized instructions. Psychometric data of all tests are 
available in standard neuropsychological tests (Lezak, 1995; Spreen & Strauss, 1998) or 
are provided in the following section if not readily available.
All testing was conducted by the primary author or other trained graduate 
students, and occurred in a quiet setting (office). There was time for questions at the 
conclusion of the examination, and the participant was given a debriefing form 
containing experimenter contact information and information regarding the nature of the 
study.
Measures
A demographic questionnaire was given to all participants (see Appendix II). The 
remainder of the measures represented standardized instruments used to arrive at clinical 
diagnoses, assess clinical symptoms, or to assess neuropsychological function. After the 
participants completed the demographic questionnaire, participants were interviewed to 
assess psychiatric symptoms. Inclusion and exclusion criteria based on these measures 
are described above in the participants section. The neurocognitive tests were 
administered following the screening and symptom rating scales. Each of the measures 
utilized in this investigation are described in the following section. All of the 
neuropsychological tests, as well as the clinician-administered rating scales and the 
structural clinical interview, are commonly used tests that have been found to be valid 
and reliable for research purposes.
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Screening and Symptom Measures
The Structured Clinical Interview fo r  DSM-IV Axis I  Disorders (SCID)
The Structured Clinical Interview for DSM-IV Axis I Disorders- (SCID-I for 
DSM-IV (SCID-DSM-IV; First, Gibbon, Spitzer, & Williams, 1996) is a semi-structured 
interview developed for obtaining DSM-IV Axis I diagnoses. It is administered by 
individuals trained in the DSM-IV diagnostic system (APA, 1994) and is utilized with 
both psychiatric and general medical patients, as well as, with individuals in the 
community for the purpose of mental health surveys and research. All o f the standard 
modules were administered, with the exception of the specific phobia and eating 
disorders sections. Scoring or rating o f the SCID modules involves rating each response 
to the diagnostic criteria either as 1 (symptom is absent), 2 (subthreshold symptom) or 3 
(symptom is present). Diagnosis of an Axis I disorder is based on the DSM-IV. A rating 
of three is endorsement of the symptom. Kappa values range from .02 to .98 with the 
majority of the values ranging from .4 to 1. There is a very low rate of false negatives. A 
study conducted by Fennig et al. (1994) suggests that the SCID is a valid instrument for 
the diagnosis of schizophrenia, as SCID schizophrenia diagnoses displayed good 
sensitivity (.89), specificity (.96), and agreement (.86) when compared to best estimate 
diagnosis made by psychiatrists on first-admission psychotic patients.
PTSD Checklist-Civilian (PCL-C).
On the PCL-C (Weathers, Litz, Herman, Juska & Keane, 1993), participants are 
asked to rate how often they experience the 17 symptoms characteristics o f PTSD within 
the last month. The potential answers are in a Likert scale format with “ 1” representing 
“Not at all” and “5” representing “Quite a Bit”. In this version of the PCL, questions are
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written generically so they could apply to any traumatic event. This questionnaire can be 
used for diagnosis in two different ways. The items can be added to receive a total score 
and then a specified cut-off will indicate the presence of PTSD (30 is the recommended 
low cut-off). Another option is to utilize the scale, following the criteria of diagnosis for 
PTSD set forth by the DSM-IV. The questions on the PCL can be broken down into the 
three clusters described in the DSM-IV: persistent re-experiencing, persistent avoidance 
of trauma related stimuli and numbing, and hyperarousal symptoms. A score of three or 
more is considered endorsement of the symptom. There must be at least I re- 
experiencing symptom, 3 avoidance items, and 2 symptoms of increased arousal. Criteria 
must be met for all three clusters of symptoms. This study utilized the latter method for 
diagnosis and total scores in statistical analyses. Test-retest reliability is .96 and item 
scale total correlations range from .62-.87. There is high convergent validity with other 
scales like the Mississippi Combat Scale (.93), and the PCL-C has similar sensitivity 
(.82) and specificity (.83) to the SCID. This measure has also been used in populations 
with severe mental illness.
B rief Psychiatric Rating Scale (Overall, Gorham, 1962; BPRS).
The BPRS consists of 18 items designed to assess 18 constructs representing 
various psychiatric symptoms. It is administered in a semi-structured interview format. 
Lach item is evaluated on a 7 point Likert scale with “ I ” representing “not present” and 
“7” representing “very severe”. The Brief Psychiatric Rating Scale (BPRS) is commonly 
employed in the assessment of clinical symptoms associated with schizophrenia and other 
psychiatric disorders. Symptoms are rated both by subjective and objective reports. The 
BPRS interview was conducted at the same time as the SCID for the clinical groups.
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The Calgary Depression Rating Scale (Addington, Addington, and Schissel, 1990;
The CDS is a nine item scale specifically developed to assess depressive 
symptoms in individuals with schizophrenia. The items are rated on a Likert scale format 
on a four point scale with “0” representing “never” and a “3” representing “severe”.
Items are rated from the patient’s responses to questions in an interview format and the 
last item is a subjective response from the interviewer. The items are designed to be 
more representative of the depressive symptoms experienced by individuals with 
schizophrenia that are not influenced by antipsychotic medication. The scale has an 
internal consistency of .76.
Scale fo r  the Assessment o f  Positive Symptoms (SAPS; Andreasen, 1984).
The SAPS is designed to assess the positive symptoms associated with 
schizophrenia. The scale is a complementary scale to be used with the SAPS. A 
structured clinical interview draws on direct observations o f behavior and subjective 
reports o f behavior. The scale provides clear definitions o f each one of the statements 
and a scaled anchor system. Several items measuring the same construct are then 
compiled into a global rating. The SAPS has the following global ratings: 
hallucinations, delusions, bizarre behavior, and positive formal thought disorder.
Scale fo r  the Assessment o f  Negative Symptoms (SANS; Andreasen, 1984).
The SANS is the complement to the SAPS designed to assess the negative 
symptoms associated with schizophrenia. Once again, a structured clinical interview is 
designed to obtain objective and subjective ratings o f behavior. Behaviors are rated 
individually and then grouped into domains for a global rating. On the SANS the global
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ratings are affect, alogia, avolition, anhedonia and attention. Before each category 
definitions are provided for each symptom. There are also behavioral anchors for each 
symptom.
Neuropsychological Test Battery Domains 
Executive Function Domain
Trail Making Test - Part B. The Trail Making Test - Part B requires the examinee 
to connect numbers and letters in alternating order with speed and efficiency. For 
example, the examinee must connect the number 1, then the letter A, then the number 2, 
followed by the letter B and continuing in this fashion until the end of the test. Trails B is 
a measure of visuomotor processing speed and executive functioning, as it requires the 
ability to process items within a visual field and manually trace those items, while 
constantly shifting cognitive set. The score is obtained by calculating the total amount of 
time (in seconds) required for task completion. Psychometric properties of the Trail 
Making Test are detailed under the Trail Making Test- Part A section. If the participant 
had difficulty completing the task. The Trail Making Test Part B was discontinued after 
five minutes and the participant would receive a score of 301 seconds to indicate that 
they could not complete the test.
Wisconsin Card Sorting Test (WCST). In the Wisconsin Card Sorting Test, 
participants are asked to categorize test cards to one of four stimulus cards placed in front 
of them. The stimulus cards consist of a red triangle on the first card, two green stars on 
the second, three yellow crosses on the third, and four blue circles on the fourth card.
The test cards consist of different geometric forms, which have a different shape, number, 
and color of stimuli. The subject is given one card at a time and asked to sort according
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to an underlying principle, with no other instructions except that they would be given 
feedback regarding their performance. The categorization rule shifts after ten successful 
responses, unknowingly to the participant, and then the subject must shift their sorting 
rule accordingly. This test measures, among other concepts, abstract concept formation 
and the ability to shift cognitive sets as feedback is given. The WCST has been shown to 
be sensitive to dorsolateral preffontal cortex (Sullivan, Mathalon, Zipursky, Kersteen- 
Tucker, Kight, et al., 1993). The dependent measures used in this test are the percentage 
of perseverative errors and the number of categories completed.
Controlled Oral Word Association Test (COWAT). The Controlled Oral Word 
Association Test is a measure of verbal fluency. Participants are asked to generate as 
many words as possible beginning with a given letter (phonetic fluency) or a specific 
category (semantic fluency) within a 60 second time period. The most commonly used 
letters are F, A, and S, which were the letters used in this study. Proper names are not 
allowed nor are the same words with different endings or suffixes. The second portion of 
the COWAT involves category or semantic association in which a participant is asked to 
generate as many items of a particular category within 60 seconds, with the most 
common categories including animals, things in the kitchen, things to wear, etc. The 
semantic category of animals was used in this study. The semantic category fluency test 
has been shown to activate primarily right dorsolateral and medial frontal region 
(Cardebat et al., 1996), whereas the letter fluency category has been found to be more 
sensitive to left frontal and temporal regions (Loring et al., 1994). The score used is the 
total number of words minus intrusion errors and perseverative responses.
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Attention Domain.
Stroop- Color/Word Association Test (Stroop, 1935; Golden, 1978). The S troop 
was administered by computer. The participant was asked to identify the color of words 
as quickly as possible. The participant was first given a practice trial to leam the task. 
The practice trial began by teaching the participant how to name the color o f the word. 
The color name and the color that the word was printed on are congruent. After several 
trials, the stimuli may be printed in one color, but the word is another color. For 
example, the word may say red, but be printed in the color blue. The correct response 
would be “blue”. These trials are considered the interference trials and represent the 
ability to suppress the undesired response. The trials are administered in a random 
sequence, with some trials printed in matching colors and words (congruent) and others 
that are incongruent (words are printed in a different color than they read). The 
dependent variable in this study was the accuracy o f the response.
Trail Making Test -  Part A. The Trail Making Test is a measure o f attention, 
which also contains a motor component (Lezak, 2004). It has proven sensitive to 
detecting cognitive impairment resulting from brain related abnormalities in numerous 
clinical populations, including schizophrenia (Crockett et al., 1988). The test contains 2 
parts. Part A and Part B. Part A is primarily considered a measure of attention, whereas 
Part B is more frequently considered a measure o f executive function. Part A consists of 
25 numbers in which the examinee is required to connect in sequence of ascending order 
under timed conditions. The subject is instructed to connect the circles as quickly as 
possible, without lifting the pencil from the paper. Performance on part A is measured by 
calculating the amount of time (seconds) required to connect all the numbers in the
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appropriate sequence. Reliability estimates reported for the Trail Making Test have been 
variable, with r values ranging from .36 to .94; however the majority of reliability scores 
exceed .60 (Spreen & Strauss, 1998).
Motor Function
The Finger Tapping Test. The Finger tapping test is an index of psyehomotor 
speed and eontrol, whieh is used to deteet subtle motor and cognitive impairment (Spreen 
& Strauss, 1998). In the Finger Tapping Test, partieipants are instrueted to use the index 
finger of their preferred hand to tap a lever as rapidly as possible for a total of five 
eonsecutive 10-seeond trials. Examinees are restrieted to using the index finger only, 
refraining from moving any other fingers. A break is generally provided after the third 
trial. Procedures are then repeated using the non-dominant hand for five trials. A final 
Finger Tapping score is obtained for dominant and nondominant hands by averaging the 
number of taps obtained on the five trials. Additional trials are administered upon the 
oceurrenee o f a variation of more than 5 taps from the highest to the lowest trial. This is 
done to obtain an aeeurate estimate of performanee. In instanees where examinee 
performanee varied by greater than 5 taps within the 5 trials, a maximum of ten trials 
were administered, and the final tapping seore is obtained by averaging seores of five 
trials within the range of five taps or less.
Purdue Pegboard. The Purdue Pegboard measures gross movement of arms and 
hands, along with fine movement dexterity. Tiny silver rods are plaeed into holes in a 
board. The dependent measure of the test is the number of pegs plaeed within 30 
seeonds. There is a trial for the dominant hand, the non-dominant hand and both hands 
together. The test-retest reliability ranges from .85 to .90.
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Working Memory
Digit Span Forward from the WMS-IIL On the Digit Span Forward participants 
are read a series of numbers and asked to repeat them verbatim. The sequences start at a 
series of 2 numbers and increase by one number every two trials until the participant 
performs two consecutive trials of the same sequence length incorrectly.
Digit Span Backward from the WMS-IIL On the Digit Span Backward the 
participant is read a series o f numbers and asked to repeat them backwards. The 
sequences start at 2 numbers and increase by one number every two trials until the 
participant performs two consecutive trials of the same length incorrectly. The total 
number of correct trials can be summed for both digits forward and backward for a total 
score.
Spatial Span Forward from the WMS-IIL The Spatial Span Forward is the visual 
analog of the Digit Span sub test. The Spatial Span Forward measures an individual’s 
ability to hold a sequence o f blocks tapped on a board in working memory and to then 
reproduce the sequence. The board is three-dimensional with ten blue blocks protruding. 
The examiner taps out a fixed sequence of patterns at a rate o f 1 block/second.
Spatial Span Backward from the WMS-IIL The Spatial Span Backward test uses 
the same apparatus as the Spatial Span Forward. The examiner once again taps out a 
design on the blocks. This time, the participant must hold the design in memory and then 
repeat the design backwards.
Explicit Memory
Verbal Memory— California Verbal Learning Test I I  (CVLT; Delis, Kramer, 
Kaplan, & Ober, 1987). The CVLT was used as a measure of declarative verbal learning
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and memory. The word lists are presented over five trials. The words on this list include 
sixteen commonly used shopping items (List A), representing various categories such as 
spices, tools, fruits, and clothes. Words are presented at the rate of one per second, and 
the participant is asked to recall as many words from List A following each presentation 
of the list. After five trials, a second list (List B) is introduced as a distractor list, and the 
participant is asked to recall as many items as they can from this second list. After 
recalling the words from the second list, the participant is asked to recall and repeat the 
words from the first list again without the list being repeated. Following the short-delay 
recall trial, the participants are cued with the categories of fruit, clothing, tools, and 
spices (Cued recall) and are again asked to recall as many items as possible in each 
category. Following a 20-minute delay in which non-verbal tasks are performed, the 
participants are asked to recall as many items from list A in both a free recall and cued 
situation. The final component of the test is recognition of stimulus words. The trial 
includes a listing of words with some words from the first list, some words from the 
second list, and some words that were not included in the test. The participant is 
instructed to answer “yes” if the word was on the first list and “no” if the word was not 
on the first list. Therefore, the CVLT measures recall, recognition and list learning; 
interference effects and retrieval/encoding difficulties can also be evaluated with this 
measure. The dependent variables to be used in this study were the total number of 
words recalled on trials one through five, the number of words recalled on list B, the 
short-delay number o f words recalled, the number of words recalled on the long-delay 
and the number correct on the recognition trial.
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Visual Memory—Biber Figure Learning Test-Extended (BFLT-E; Glosser et al., 
1997). The BFLT-E will be used as a measure of visual or non-verbal learning and 
memory. The BFLT-L has been described as the visual analog of the California Verbal 
Learning Test (Kurtzman, 1996; Traci, Mattson, King, Bundick, Celenza, & Glosser, 
2001; Glosser, Cole, Khatri, DellaPietra, & Kaplan, 2002), such that both tests involve a 
series o f five learning trials, an interference task, as well as, an immediate recall, delayed 
recall condition, and a recognition trial. The BFLT-L, a modification of the original 
Biber Figure Learning Test, (BFLT; Glosser et al., 1989), and consists o f 15 geometric 
designs constructed of simple shapes (circles, squares, and triangles) put together to form 
novel stimuli. The fifteen designs are presented one at a time at a rate of one every 3 
seconds. Following presentation of the designs, the participant is asked to draw as many 
of the figures as he/she can recall in no particular order. This is done for five trials. Then 
similar to the CVLT, an interference task is introduced with distractor figures followed 
by an immediate free recall trial of the original list. A delayed learning recall trial is 
administered 20 to 30 minutes later, with verbal (non-visuospatial) tasks conducted in the 
delay. A recognition trial asks the participant to identify the designs from the first list. 
The Biber Figure Learning Test is scored on a scale of zero to three for each stimuli. 
Although the CVLT and the BFLT-L are not identically matched in terms of difficulty 
level and item content, they can serve as relative measures o f verbal and non-verbal 
learning (Tracy et al., 2001). The inter-tester reliability has been found to be .98. (Glosser 
et al., 2002). The BLFT-L has also been shown to have good test-retest reliability and 
criterion validity (Glosser et al., 2002) and to demonstrate sensitivity to non language- 
dominant right temporal lobe functioning.
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Emotional Memory—Emotional Verbal Learning Test (EVLT; Strauss & Allen, 
unpublished manuscript). The EVLT is a measure of learning and memory for emotional 
words. All procedures, parameters, and score calculations are modeled after the CVLT-II 
(Delis, 2000), allowing for a direct comparison between learning and memory 
performance for emotional and neutral words. The LVLT is a standardized measure with 
psychometric properties comparable to the CVLT-II (internal consistency, r = .88).
The task first requires the experimenter to orally present 16 words (List A) over five 
immediate-recall trials. The list consists of 4 words from each o f four “basic emotion” 
categories (Happiness, Sadness, Anger, and Anxiety). Individual words of the same 
category are never presented successively to allow for the assessment of semantic 
clustering. Following the 5 immediate recall presentations, a second “interference” list 
(List B) is presented for a single trial. Immediately following List B, a short delay free 
and eategory eued recall o f List A is administered. A 20-minute delay then oceurs 
between the presentation of the short-delay and long-delay free reeall assessments. Long 
delay free and cued recall is then assessed. Recognition of List A is measured using a 
yes-no recognition format immediately following the administration of the long delayed 
reeall. In the test of reeognition, there are 28 distractors consisting of: List B emotional 
words semantically related to List A words. List B emotional words semantically 
unrelated to List A words (disgust words), novel words that are prototypical of semantic 
categories presented in list A, and emotional words semantically unrelated to List A 
words (fear and surprise words). Normative data collected on the LVLT suggest that 
psychologically healthy individuals evidence a memory bias for happiness words (Strauss
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& Allen, unpublished manuscript). This memory bias is not accounted for by list order, 
word frequency, word length, or emotional prototypicality.
Estimates o f  Intelligence Function.
The following three tests are subtests from the WAIS-III, the Wechsler Adult 
Intelligence Scale 3rd edition (Wechsler, 1997).
Block Design. On the Block Design subtest individuals are asked to make a series 
of designs utilizing blocks. The blocks each have one red side, one white side, and two 
sides that are half-red and half-white. The designs begin with a pattern utilizing only four 
blocks and get progressively more difficult to designs necessitating nine blocks. Designs 
must be administered in discrete amounts of time. Responses are scored for accuracy and 
time to complete. The administration of this subtest is discontinued after three trials that 
are not completed correctly.
Information. On the Information subtest, the participant is asked to answer several 
questions. Questions represent a general fund of knowledge from multiple content areas 
including geography, history, science, etc. Answers receive one point for a correct 
answer. The subtest is discontinued after six consecutive incorrect trials.
Vocabulary. On the Vocabulary subtest, participants are asked to give definitions 
to increasingly difficult words. Responses may be given up to two points and may 
receive partial credit.
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CHAPTER 4 
RESULTS
Preliminary Analyses
The raw data were examined to detect any out-of-range variables. All of the 
variables were then checked to determine if they were normally distributed. Some 
variables exceeded acceptable limits for skewness and kurtosis. These included the Trail 
Making Test part A, the Stroop total scores, and the recognition scores on the CVLT and 
Biber Figure Learning Test.
Although multivariate analysis of variance (MANOVA) has been found to be 
relatively robust with respect to violations in assumptions o f normality and homogeneity 
(Tabachnick & Fidel, 2001), the variables identified above were converted to ranked 
scores and then entered in parametric analyses, to ensure that the variables were not being 
overly influenced by non-normal distributions. The parametric analyses were conducted 
first followed by the method described above to correct for non-normality. Both 
parametric and nonparametric results will be discussed in the corresponding sections.
Following inspection o f the data, preliminary analyses were conducted to examine 
demographic differences among the groups. For these analyses, one-way analyses of 
variance (ANOVA) were used for age and education, and chi-square analyses were used 
for categorical variables (ethnicity, sex, gender). The results of these analyses as well as 
the descriptive data for each group are presented in Table 1. The ANOVA for age was
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significant, with post-hoc analyses indicating that the PTSD group was significantly 
younger than the Controls and schizophrenia groups. On the other hand, the Control, SZ, 
and SZP groups did not significantly differ from one another. The ANOVA for 
education was also significant, although post-hoc analyses did not reveal any significant 
differences between any of the groups. The ethnicity of the groups was compared using a 
chi-square analysis. The results of the test were not significant, (21, V  = 92) = 29.07, 
/?=.10. The chi-square for gender was significant (3, V  = 90) = 10.24, p  = .02. 
Consistent with prior studies investigating the percentage of trauma in individuals with 
schizophrenia, 76% of the individuals with schizophrenia had been exposed to a 
traumatic event.
Evaluation o f  Study Hypotheses/Main Analyses
Following the preliminary analyses, MANOVA was utilized to evaluate the study 
hypotheses. The first hypothesis regarded differences in psychiatric symptoms among 
the groups, while the remaining three were concerned with differences in 
neuropsychological function. Tables 1-17 contain descriptive statistics as well as the 
results o f the statistical analyses and post hoc (Scheffé) tests for all eight 
neuropsychological domains. Composite scores were derived by summing and averaging 
the z-scores of the measures in a particular domain. To calculate z-scores, the means and 
standard deviations o f the raw scores from the normative sample were used. Figure 4 
demonstrates the pattern of neurocognitive performance across domains by group.
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Hypothesis One:
On schizophrenia symptom measures (SANS, SAPS, and BPRS) the SZ srouys will 
score sisnificantlv higher than the PTSD sroup. In resard to the SZ and SZP 
groups, it is predicted that the SZP sroup will score hisher on the SAPS, the 
measure o f  positive symptoms o f  schizophrenia, and that the SZ sroup will score 
hisher on the SANS, a measure o f  negative symptoms, and the BPRS, a measure 
o f  more global psychiatric symptoms. It is hypothesized that the two groups with 
PTSD will score higher than the SZ control group on other symptom measures 
(CDS and PCD.
Separate MANOVA's were used to compare the groups on clinical symptoms as
assessed by the SANS and SAPS, and ANOVA’s were used to compare the groups on the
BPRS Total Score, the Calgary Depression scale and the PCL Total Score. The statistics
for the symptom ratings for the three clinical groups are presented in Table 2 with the
corresponding values for the statistical analyses. For the SANS, the overall MANOVA
was significant F(10,122) = 6.54,/? < .001, with the SZ group scoring higher than the
SZP group on the SANS subscales. Because the MANOVA was significant, subscale
ratings were accomplished to evaluate if  there was a differential pattern o f symptoms
within the measures. The PTSD group scored significantly lower than the SZ groups on
all of the subscale scores. Scheffe post-hoc analyses indicated that all three groups were
significantly different from one another on the affective flattening subscale score with the
SZ group having the highest score and the PTSD group with the lowest score. On the
alogia, avolition-apathy, anhedonia-asociality, and attention subscales thé SZ and SZP
groups did not differ significantly from one another, but were significantly different from
the PTSD group. For the SAPS, the overall MANOVA was also significant F(8,124) =
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15.46,/? < .001. The pattern of symptoms on the SAPS was different than what was seen 
on the SANS, with the SZP group scoring higher than the SZ group on some o f the SAPS 
subscales. The SZP group scored higher than the SZ group on the hallucinations and 
delusions subscales indicating more severe symptoms in the SZP group. The SZ and SZP 
groups scored significantly higher than the PTSD group. Conversely, on the bizarre 
behavior and thought disorder subscales the SZP group scored lower than the SZ group. 
The SZP and PTSD groups were not significantly different on these two ratings.
Separate ANOVA’s revealed significant differences on the CDS, BPRS and the PCL. 
On the CDS the SZ group scored significantly lower than the PTSD group and the SZP 
group, indicating more depressive symptoms in the PTSD and SZP groups. All three 
groups differed on their PCL scores with the SZ group scoring the lowest followed by the 
PTSD group. The SZP group received the highest scores on the PCL, indicating the 
highest level o f PTSD related symptoms. On the BPRS the PTSD had significantly lower 
symptoms than the SZ and SZP groups and the SZP group had higher symptom scores 
than the SZ group, once again, indicative o f increased levels of overall psychiatric 
symptoms.
Hypothesis Two:
On the motor domain measures, there should he no difference between the SZ  
and SZP groups. Additionally, the PTSD and Control groups will score 
significantly higher or exhibit no impairment in comparison to the SZ and SZP 
groups.
Descriptive statistics and MANOVA results for motor functioning are presented 
in Table 3. As depicted in the table, the overall MANOVA was significant F  (15,258) =
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2.78,/? < .001. All univariate tests were also significant. Scheffe post-hoc analyses 
indicated that on all of the measures, the Controls and PTSD groups had the best 
performance. On pegboard scores, Scheffe post-hoc analyses indicated that the SZP 
group was not significantly different than the other three groups.
Because o f the known associations between neuropsychological test performance 
and variables such as age, education and positive and negative symptoms, the impact of 
these variables on the motor differences among the groups was examined using a series 
of covariate analyses. In the first of these analyses, effects of age and education were 
examined by including age and education as covariates in a MANCOVA. The results of 
these analyses indicated that age was not a significant covariate, F(5,82) = .72,/? = .61, 
nor was education, F(5,82) = 1 . 1 1 , / ? =  .36. Furthermore, the overall effect for groups 
remained significant, F(15,252) = 2.38, /? = .01. Inspection of the means for the 
individual test scores after covarying out the effects of age and education further 
suggested that while there were some minor changes in values, the overall pattern of 
differences among the groups remained the same. See Table 9 for comparison of the 
descriptive statistics corrected for age and education.
Similar analyses were then accomplished for symptoms variables, specifically the 
SANS and SAPS total scores and the PCL total score, as there were also significant 
differences among the groups on these variables. The results of these analyses indicated 
that the SANS was not a significant covariate, F(5,80) = .14, /? = .98, nor was the SAPS, 
F(5,80) = .23, p  = .95, or the PCL, F(5,80) = .102, /? = .41. Although none of the 
symptom measures were significant, the overall effect for group was no longer significant 
in the MANCOVA F  (15,246) = 1.27,/? = .22. Inspection of adjusted means revealed
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little effect of the covariates on raw motor scores. Thus, the lack of an overall difference 
may have resulted from decreased power with the inclusion of covariates.
Hypothesis Three:
For this hypothesis it was predicted that:
1. On measures o f  neurocognitive impairment including explicit memory 
(verbal and spatial), working memory (verbal and spatial), emotional 
memory, executive function and attention, all three clinical groups would 
exhibit impaired performance relative to Controls.
2. The comorbid group would have significantly more impairment than 
either the PTSD or SZ group.
3. The level o f  impairment would be more than the deficits associated 
with either schizophrenia or PTSD combined supporting a synergistic 
model o f  neurocognitive deficits.
Results o f the separate M ANOVA’s, one for each of the six neurocognitive 
domains provided partial support for the first hypothesis. As can be seen in Tables 4 -7, 
these MANOVA’s revealed significant overall differences in the domains of Verbal 
Learning/Memory, Visuospatial Learning/Memory, Emotional Learning, Working 
Memory, Executive Functioning, and Attention. The pattern o f differences among the 
groups generally indicated that the Control group performed significantly better than the 
SZ groups. The PTSD group was not, however, signifieantly different from the Control 
group on most tests. Additionally, the SZ and SZP groups were not statistically different 
from each other throughout. As predicted though, the SZ and SZP groups did exhibit a 
pattern o f performanee within domains suggesting that PTSD in individuals with
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schizophrenia may influence neurocognitive symptoms. This pattern was however, 
contrary to the hypothesis, in that the SZP group tended to have better performance than 
the SZ group.
A MANOVA was used to compare the groups on measures of memory. See 
Table 4 for descriptive statistics and statistical analyses. Separate MANOVA’s were 
conducted for each of the memory domains. Verbal Learning and Memory was assessed 
with the CVLT. Visual Spatial Learning and Memory was assessed using the Biber 
Figure Learning Test and Emotional Learning was assessed with the EVLT. All of the 
aforementioned memory tests are similar to one another in that they have the same 
performance indices. All o f the aforementioned memory tests included a total score for 
trials 1-5, a distractor trial, a short-delay trial, a long-delay trial and recognition section.
Verbal Learning/Memory
The overall MANOVA was significant for the CVLT, F (2 1,252) = 3.66, p  <
.001. O f the specific trials, univariate statistics revealed that all of the variables with the 
exception o f the recognition section were significant. Results of univariate F tests are 
presented in Table 4. Scheffe post-hoc analyses indicated that the Control and PTSD 
group were significantly different from the SZ and SZP groups. There were no 
differences between the Control and PTSD groups or between the SZ and SZP groups. 
While the results were not significant, the SZP group consistently scored higher than the 
SZ group, whereas there was no consistent pattern between the Control and PTSD group.
Once again, a series of MANCOVA’s were performed to evaluate the effects of 
age, education, and psychiatric symptoms on the verbal learning scores. The univariate 
analysis for age was not significant F(4,83) = 1.14,/? = .36 and the univariate analysis for
88
education was not significant F(4,83) = .69, p  = .60, although the effect for group 
remained significant F(12,255) = 5.00,p  < .001. Similar analyses were then 
accomplished for the symptom variables. The results of these analyses indicated that the 
SANS was a significant covariate, F(4,81) = 3.02,p  < .05. On the other hand, neither the 
SAPS, F(4,81) = .91,/? = .46, or the PCL, F(4,81) = .71, /? = .58 were significant. Since 
the SANS was the only covariate exerting an effect upon the variables, another 
MANCOVA was run with only the SAPS as a covariate, so as not to decrease power with 
variables that were not a significant influence. This MANCOVA was significant F(5,57) 
= 2.15,/? = .07. The overall effect of group F( 10,116) = 2 .90,/? < .01. Table 11 
provides the corrected and uncorrected descriptive statistics for the Verbal 
Learning/Memory domain. Finally, the recognition scores were converted to ranked 
scores and compared with an ANOVA to better evaluate if  the violations of normality 
influenced previous results from the parametric tests. The ANOVA for the ranked cases 
yielded the same results as the parametric analyses. The recognition scores remained 
non-significant, F(2,91) = .87, p  = .47.
Visual Learning/Memory
A MANOVA was then used to compare the groups on visual spatial memory 
using the Biber Figure Learning Test. See Table 4 for descriptive statistics and statistical 
analyses. The overall MANOVA was significant F(15,246) = 3.99, p  < .001. Univariate 
ANOVA’s documented significant differences on all of the variables. On all of the 
variables, with the exception o f the recognition trial the Control and PTSD groups were 
significantly different from the SZ and SZP groups. On the recognition section the SZP 
group scored closely enough to the Control and PTSD group that it was not a significant
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difference. While the differences did not attain significance throughout all o f the free 
recall trials, the Control group scored higher than the PTSD group. Similarly, as in the 
verbal memory domain, the SZP group consistently scored higher than the SZ group.
Once again, a series of MANCOVA’s were performed to evaluate the effects of 
age, education, and psychiatric symptoms. Age and education were not significant 
covariates. The effect for group was still significant F(15,240) = 3.55,/? < .001. Similar 
analyses were then accomplished for symptom variables, the SANS, SAPS and the PCL. 
The results of these analyses indicated that the SANS F(5,76) =1.81, /? = .12, SAPS 
F(5,76) = .81, /? = .55, and the PCL F(5,76) = .73,/? = .60 were not significant. See 
Table 12 for a comparison of the corrected and uncorrected statistics on the Visual 
Learning/Memory domain. Finally, recognition scores were ranked and entered in the 
ANOVA because o f the violations of normality. The ANOVA remained significant F  
(3,82) = 10.57,/? < .001, indicating that the violation of normality did not influence the 
results from initial parametric analyses. The recognition scores were still significantly 
different between the groups.
Emotional Learning/Memory
A MANOVA was used again to compare the groups on the final memory domain. 
Emotional Memory. The overall MANOVA was significant F(15,258) = 4.08,/? < .001. 
All o f the univariate analyses were also significant. Post-hoc analyses indicated that the 
Control and PTSD groups were statistically different from the SZ and SZP groups.
Once again, MANCOVA’s were used to analyze the effects o f age and education 
on emotional learning. The univariate analysis for age was not significant F(5,82) = 1.29, 
/? = .28, and the univariate analysis for education was not significant F(5,82) = 1.76,/? =
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.13. Similar analyses were then accomplished for symptom variables, the SANS, SAPS 
and the PCL. The results of these analyses indicated that the SANS was not a significant 
covariate F(5,80) = 2.16,/? = .07, nor was the SAPS F(5,80) = 1.38,/? = .24, or the PCL 
F(5,80) = .91,/? = .48. See table 13 for a comparison of the corrected and uncorrected 
means on the Emotional Learning/Memory domain.
Working Memory
With regard to the MANOVA for the Working Memory domain, the overall 
MANOVA was significant, indicating significant differences between the groups. See 
Table 5 for a description of group performances for the Working Memory domain 
measures. Univariate ANCOVA’s yielded significant values for all of the working 
memory measures. Scheffe post-hoc analyses indicated that the Control and PTSD 
groups scored significantly higher on all of the subtests than the SZ and SZP groups, with 
the exception of the Spatial Span Backwards subtest in which the PTSD group did not 
score significantly higher than the SZP group. None of the comparisons were significant 
between the PTSD and Control group or between the SZ and SZP groups.
Once again, a series of MANCOVA’s were performed to evaluate the effects of 
age, education, and psychiatric symptoms on the Working Memory domain because of 
the differences between the groups on these variables. The univariate analysis for age 
was not significant F(4,82) = 1.45,/? = .23, but the univariate analysis for education was 
significant F(4,82) = 2.78,/? < .05, however, the overall effect for group remained 
significant F(12,252) = 3.97, /? < .001. In determining how the covariates influenced the 
Working Memory domain, between subjects effects indicated that education was a 
significant covariate on Digit Span Backward and on the Spatial Span Backward scores.
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suggesting that there is an association between education and more complex working 
memory tasks, as the backward portions require the ability to hold and manipulate 
information rather than just recalling strings of stimuli as in the forward task. Once 
again, the pattern of differences among the groups remained the same and there were 
only small changes in the descriptive statistics based on the weighted means. See Table 
10 for a comparison of the descriptive statistics for weighted and unweighted means.
Similar analyses were then accomplished for symptoms variables, the SANS, 
SAPS and the PCL. The results of these analyses indicated that the SANS was a 
significant covariate, A(4,81) = 3.41,/? < .05. On the other hand, neither the SAPS 
A(4,81) = 1.15, p  -  .15, or the PCL A(4,81) = .46,/? = .76 were significant. Since the 
SANS was the only covariate exerting an effect upon the variables, another MANCOVA 
was run with only the SANS as the covariate. This MANCOVA was significant F(4,58) 
= 3.09, p  < .05. The SANS was significant on the Spatial Span Forward. The overall 
effect of group was still significant, F(8,l 18) = 3.13,/? < .01. See Table 10 for a 
comparison of the corrected and uncorrected means on the Working Memory domain. 
Executive Function
MANOVA was then used to compare the groups on the Executive Function 
domain. See Table 6 for descriptive statistics on the Executive Function domain. The 
overall MANOVA was significant, F(15,258) = 4.28,p  < .001. Post-hoc analyses 
indicated that, in general, significant differences were present between the Control and 
PTSD groups and the SZ and SZP groups. There were two occasions when this was not 
the case. On the number of categories completed on the WCST, the PTSD group did not
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significantly differ from the SZP group. Also on the COW AT FAS total the Control 
group did not significantly differ from the SZ group.
The MANCOVA’s using age and education as the covariates were not significant 
for age F(5,82) = \.9A ,p  = .10, or for education F(5,82) -  \ .5 \ ,p  = .20. The effect for 
group was still significant A( 15,252) = 3.81,j? < .001. The MANCOVA using the 
symptom measures as covariates indicated that the SANS was a significant covariate 
F(5,80) = 2.56, p <  .05, although the SAPS and the PCL were not significant covariates, 
F(5,80) = l.6A ,p  = .16, and A(5,80) = .55,p  = .88, respectively. Because the SANS was 
the only symptom measure to exert a significant effect on the executive function 
measures, the MANCOVA was run again, using only the SANS as the covariate. The 
MANCOVA was significant, F(2,57) = 2.0S,p  = .16. The SANS significantly influenced 
the Trail Making Test Part B and the COW AT Animal scores. The overall effect for 
group was significant F( 10,116) = 2.29, p  < .02. See Table 14 for the corrected and 
uncorrected means on the Executive Function domain.
Attention
A MANOVA was used to compare the groups on the final neurocognitive 
domain, Attention, see Table 7. The overall MANOVA was significant F (6 ,174) = 6.59, 
p  < .001. The univariate statistics were also significant on both of the measures, the 
Stroop F(3,91) = 9.64,p  < .001, and Trails A F(3,91) = 5.20,p  < .01. Post-hoc analyses 
indicated that the PTSD group was significantly better different than the SZ and SZP 
groups on the Trails A. The Control group performed significantly better than the SZ 
group. On the Stroop, the PTSD and Control group performed significantly better than 
the SZP group. Inspection of the descriptive statistics suggests that the presence of PTSD
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may increase attention as measured by the Trail Making Test part A. On the Stroop we 
see the same pattern where the PTSD and SZP groups score lower than the Control group 
and SZ group, respectively. Lower scores on the Stroop reflect poorer accuracy, 
suggesting that PTSD influences accuracy.
The MANCOA with age and education as the covariates was significant for age 
F(2,84) = 5.65,p  < .05, but not for education F(2,84) = 2.94,p  = .06, although it 
approached significance. The overall effect for group was still significant F(6,170) = 
4.80,/? < .001. Inspection of the between subjects effects indicated that age and 
education significantly influenced the Trails A scores. The symptom measures 
MANCOVA was significant for the SANS F(2,82) = 5.75,/? < .01. The SAPS and PCL 
were not significant F(2,82) = .68,/? = .51, andF(2,82) = 1.35,/? = .27. Because the 
SANS was the only symptom measure to exert a significant effect on the attention 
measures, the MANCOVA was run again, using only the SANS as the covariate. The 
MANCOVA was significant, F(2,59) = 4.53,/? < .05 and the SANS significantly 
influenced Stroop scores. The overall effect for group was still significant F(4,120) = 
2.61,/? < .05. See Table 15 for a comparison of the corrected and uncotrected means on 
the Attention Domain.
Since the Trail Making Test part A and the Stroop total score violated the 
assumptions of normality, scores were ranked and the analyses were conducted again, to 
correct for the violations in the assumptions of normality. The MANOVA was 
significant F(6,174) = 7.71,/? < .001. Univariate tests were also significant for both 
variables. Post-hoc analyses indicated that the Control and PTSD group were 
significantly different from the SZ and SZP groups on Trails A scores. On the Stroop,
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the Controls were significantly different from the SZP group, indicating that the SZP 
group made the most errors and the Control group made the least errors. Overall results 
of the non-parametric tests support findings of parametric analyses.
Hypothesis four:
The SZ and SZP sroups will have sisnificantly lower scores on the WAIS-III 
subscales: Information, Vocabulary and Block Desisn.
A MANOVA was used to compare the groups on subtests from the WAIS, 
measures o f cognitive function, see Table 8. The overall MANOVA was significant 
F(9,261) = 4.74,/? < .001. Scheffe post-hoc analyses yielded significant differences 
between the Control and PTSD group and the SZ and SZP groups. The Control group 
was not significantly different than the PTSD group and the SZ and SZP groups were not 
significantly different from one another. The MANCOVA with age and education as 
covariates was significant for age F(3,83) = 3.65,/? < .05. Between subjects effects 
showed that age was a significant covariate on the Block Design subtest. The impact of 
group, however, was still significant F(9,255) = 3.43,/? < .001. Education was not a 
significant covariate F(3,83) = 2.08,/? = .11.
Figure 4 summarizes the results for the hypotheses examining the neurocognitive 
domains. The figure present composite scores for each domain. The scores,for each 
domain were standardized based on the Control group’s performance, so that 
comparisons can be made across the domains for the Control, PTSD, SZ and SZP groups. 
As can be seen from Figure 4, the SZP and SZ group performed similarly on all of the 
domains with the exception of the Attention Domain, Executive Function, and Visual 
Memory Domains. The SZP group exhibited better performance than the SZ group on
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the Executive Function and Visual Memory Domains, but performed more poorly on the 
Attention Domain, showing an interactive effect o f PTSD on SZ. In comparing the 
Control and PTSD groups, the PTSD exhibited slightly poorer performance on the Visual 
Memory domain, and to a smaller extent on the Executive Function and Working 
Memory Domains. See Table 16 for comparison for adjusted and unadjusted means.
Figure 5 presents the composite scores for the neurocognitive domains as described 
above and then adjusted for age and education. As can be seen from Figure 5, the pattern 
of results parallels those described in Figure 4. The corrections for age and education 
tended to increase the differences in performance between the Controls and PTSD group 
and the SZ and SZP groups.
Figure 3. Neuropsychological composite scores of each o f the groups on all of the 
neurocognitive domains.
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Figure 4. Neuropsychological composite scores corrected for age and education for 
each o f the groups on all of the neurocognitive domains.
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CHATER 5 
DISCUSSION
This study examined the neurocognitive function in individuals with comorbid 
schizophrenia and PTSD in order to determine if the presence o f PTSD caused an 
increased level o f neurocognitive dysfunction, and if  present, whether this increased 
impairment supported either an additive or synergistic model o f impairment. The 
additive model would predict that neurocognitive deficits in the comorbid group would 
simply reflect the addition o f the deficits associated with PTSD to those already present 
as a result of schizophrenia. On the other hand, the synergistic model would reflect an 
interaction between the two disorders such that the neurocognitive deficits associated 
with the comorbid disorder would be much greater than what might be expected from the 
simple addition of the corresponding impairment associated with each disorder. This 
study also attempted,to further clarify the specific neuropsychological deficits that exist 
in individuals with PTSD and schizophrenia. Four specific hypotheses were explored to 
answer these questions. The hypotheses were partially supported by the data and will be 
discussed individually in terms of the specific findings and potential implications. 
Hypothesis One
The first hypothesis examined the psychiatric symptoms associated with each of 
the three clinical groups. As indicated by prior literature, it was expected that the 
comorbid group would evidence higher levels of positive symptoms and higher levels of
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overall psychiatric distress than the other groups. The MANOVA examining differences 
among the SZ, SZP and PTSD groups on positive symptoms was significant. As 
predicted, the PTSD group scored the lowest on all of the global domain scores of the 
SAPS. On the delusions global rating, the SZP group had significantly more delusions 
than either the SZ or PTSD groups, findings consistent with Ross, Anderson and Clark 
(1994) who found increased positive symptoms in individuals with a history of childhood 
abuse.
The SZP group was also predicted to have fewer negative symptoms than the SZ 
group. This prediction was only partially supported. On the overall SANS total and the 
affective flattening subscale the SZP group scored lower than the SZ group. The other 
subscale scores were not significant. In the only study addressing the influence of 
comorbid trauma on negative symptoms in schizophrenia did not find any differences in 
the level of negative symptoms associated with a trauma history (Schellar-Gilkey, 
Thomas, Wool wine, & Miller, 2002). However, this same study by Schellar-Gilkey and 
coworkers also did not find significant differences in the level of positive of symptoms, 
although such differences were present in the current study. In that study, two groups of 
patients with schizophrenia were compared, one that had comorbid substance abuse, and 
another that did not. Those with comorbid substance use disorders had more frequently 
experienced childhood trauma and attained higher scores on measures of PTSD 
symptoms. However, direct comparisons were not made between patients with 
schizophrenia who did or did not have PTSD.
It was also predicted that the SZP group would have higher levels of overall 
psychiatric distress. The BPRS as a measure of overall psychiatric symptoms provided
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partial support for this hypothesis, as the scores on the BPRS were significantly different 
between the groups. The PTSD group had the lowest level of overall symptoms followed 
by the SZ group. The difference between the SZ and SZP groups were not significant 
although the means were in the predicted direction. This finding of increased levels of 
overall psychiatric distress was consistent with the findings of Kim, Kaspar, Nob and 
Nam (2006) who found increased levels of distress in individuals with a history of 
physical and sexual abuse.
With regard to depression, the SZ group received the lowest scores on the CDS, 
indicating the least amount of depressive symptoms, followed by the PTSD group, with 
the comorbid group attaining the highest level of depressive symptoms. These results 
were somewhat surprising in that the PTSD group had higher levels of symptoms than the 
SZ group. This finding does, however, make sense in light of the affective component 
associated with trauma and PTSD. Furthermore, the increase in depressive symptoms 
associated with a trauma history may be related to the increased risk o f suicidality 
associated with comorbid schizophrenia and PTSD documented by Read and Ross 
(2003).
On the PCL which measures symptoms specific to PTSD, the SZ group had the 
lowest score reflecting lower symptoms, while the SZP group had the highest level of 
symptoms. The differences between all three groups were significant. Craine, Henson, 
Colliver and MacLean (1988) also documented symptoms commonly linked to trauma 
history in individuals with severe mental illness and a sexual abuse history, although they 
did not compare the individuals in their sample to a PTSD group, thereby making it 
unclear if  the SZP group would have had more symptoms than a PTSD only group.
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Additionally, Resnick, Bond and Mueser (2003) obtained similar results and further 
documented that levels of PTSD symptoms are related to increased severity o f trauma, or 
increased instances o f trauma. The majority of the sample in this study was exposed to 
more than one traumatic event. In fact, 43% of the PTSD sample had been traumatized 
only once, while 14% of the individuals in the SZP group were exposed to only one 
traumatic event. Studies have shown that multiple traumatization is associated with more 
severe symptoms and so it is possible that these groups may have exhibited increased 
levels of symptoms resulting from multiple traumatizations (Classen, Palesh, & Aggaral, 
2005).
In summary, results of symptom ratings suggest that the presence o f PTSD in 
schizophrenia is associated with increased positive symptoms, increased PTSD 
symptoms, increased depression, and increased levels of more generalized symptoms of 
psychiatric distress. On the other hand, the presence of PTSD in schizophrenia was 
associated with slightly decreased levels of negative symptoms.
Hypothesis Two
The second hypothesis evaluated motor performance among the groups. Motor 
performance was not expected to be impaired in the PTSD group or to impact the 
performance in the SZP group, because deficits in motor function are not associated with 
PTSD. As predicted, there were no significant differences between the SZP and SZ 
groups, although both groups performed more poorly than the Control and PTSD groups 
who did not differ from each other.
On the Finger Tapping Test there were no differences on the pattern of 
performance between the Control and PTSD groups. Similarly, there were no differences
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between the PTSD group and the Control group on the Purdue Pegboard. The SZP group 
performed high enough so that the mean was no longer significantly different from the 
Controls or PTSD group for either the dominant or non-dominant hands. On the trial 
using hoth hands, the pattern was the same, but there was greater disparity between the 
scores o f the Control and PTSD groups and the SZ and SZP groups. Overall results of 
motor function are somewhat conflicting. However, it is not unusual to observe these 
types of inconsistencies between dominant and non dominant hands on various motor 
tasks (Jarvis & Barth, 1994), necessitating the use o f multiple measures o f motor function 
as was used in the current study. These inconsistencies between dominant and 
nondominant had performance do however suggest that there was no strong evidence of 
lateralized dysfunction in these patients.
As predicted the Control and PTSD group exhibited similar performance across 
the motor measures. Additionally, the SZ and SZP groups exhibited similar patterns of 
performance. Interestingly, on the individual hand trials of the Purdue Pegboard the SZP 
group scored in between the scores from the PTSD group. Control group and the SZ 
group. This finding may reflect that the motor performance associated with SZP is less 
severe than that associated with schizophrenia, but as the task demands become more 
difficult or complex, the compromised resources associated with schizophrenia limit the 
performance by the SZP group, impairing performance.
Hypothesis Three
This hypothesis was designed to evaluate the pattern of neurocognitive 
performance associated with the four groups (Controls, PTSD, SZ and SZP). 
Neurocognitive performance was assessed using six domains: Attention, Working
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Memory, Executive Function, Verbal Learning/Memory, Visual Learning/Memory, and 
Emotional Learning/Memory. It was predicted that the PTSD group would exhibit some 
minor impairment in these domains, particularly on the Attention, Working Memory, 
Executive Function and Verbal Learning/Memory domains based on prior research 
(Jenkins, Langlais, Delis, & Cohen, 1998; Yehuda, Golier, Halligan, & Harvey, 2004). 
Furthermore, both o f the schizophrenia groups were predicted to perform more poorly 
than the Control and PTSD groups, with the SZP group exhibiting the worst performance 
due to the combined effects of schizophrenia and PTSD on neurocognitive function.
Consistent with this hypothesis, the SZ groups had significantly more impairment 
than the Control and PTSD groups on all of the neurocognitive domains. The PTSD 
group did not significantly differ from the Control group on any of the neurocognitive 
domains. These non-significant differences may reflect the inconsistencies in 
neurocognitive function reflected in the literature on PTSD. For example, although 
explicit verbal memory is the most researched area of neurocognitive function in PTSD, 
many studies have not found significant differences between PTSD groups and controls 
(Neylan et al., 2004; Stein, Hanna, Vaerum, & Koverola, 1999). Other research has 
suggested that results of the whole group may be confounded because only specific 
subsets of individuals with PTSD experience cognitive deficits (Sutker, Vasterling, 
Brailey, & Allain, 1995). In their sample it was only POW ’s with PTSD and who had 
high levels of arousal dysregulation that experienced cognitive deficits. Other research 
has suggested that cognitive deficits associated with PTSD would be related to current 
PTSD versus lifetime PTSD diagnosis, because the cognitive deficits may become less 
severe or reverse completely with the passing of time or through the use of medication
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(Seedat et a l, 2002). Additionally, levels of cognitive impairment may be related to the 
time in development when the traumatic event occurred (Bremner & Vermetten, 2001), 
so that individuals who experience trauma at younger ages are more likely to have 
neurostructural and neurophysiological abnormalities than those affected at older ages.
As discussed in the literature review, different types of traumatic events are associated 
with increased levels of PTSD and potentially different levels o f cognitive dysfunction. 
Since the PTSD group in this study was heterogeneous there may have been fewer 
neurocognitive impairments than a PTSD group composed of only rape survivors for 
example.
The second domain that the PTSD group would be expected to exhibit impairment 
is the Attention Domain (Gilbertson, Gurvits, Lasko, Orr & Pitman, 2001). Once again 
there was no significant difference between the Control and the PTSD group on the 
Attention Domain, although the SZP group did perform worse than the SZ group for this 
domain. In fact, this was the only instance in which the SZP group performed noticeably 
worse than the SZ group (although the difference was not significant). A possible 
explanation may be that SZP increases attention through hyperarousal. Hyperarousal has 
been associated with decreased accuracy or more false alarms based on the increased 
vigilance (Wilding, Pankhania, & Williams, 2007). This hypothesis could also be 
examined using reaction times. Wilding, Pankhania, and Williams, however, did not find 
any differences in reaction times associated with increased arousal. Additionally, all 
groups exhibited relatively high levels of accuracy decreasing the ability to detect true 
differences between the groups. This does, however, suggest that the differences 
between the SZP and SZ group may be greater with a measure with greater variability in
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scores. Additionally, the Attention Domain did not include a measure of sustained 
attention, which may result in a different pattern of performance. Koso and Hansen 
(2006) examined sustained attention and found impaired attention.
On the two other domains most related to frontal lobe function. Executive 
Function and Working Memory, results between the PTSD and Control groups were 
similar. Additionally, there were slight differences between the PTSD group and 
Controls on the Visual Learning/Memory domain. There are only a few studies, which 
have addressed the neurocognitive domain of Visual learning/memory. Bremner, 
Vermetten, Afzal and Vythillingham (2004) and Jelinek et al. (2006) both documented 
Visual Learning/Memory deficits in women with a history of childhood sexual abuse, 
whereas Yasik, Saigh, Oberfield and Halamandaris (2007) did not find any differences in 
adolescents with PTSD. In summary, the PTSD group did not exhibit impaired 
performance on any of the neurocognitive domains. There did appear to be a potential 
effect of trauma on Visual Learning/Memory, Working Memory, and Attention, which 
are areas to investigate further.
As predicted the SZ and SZP group exhibited significantly lower performance 
than the Controls and PTSD group. There were a number of instances where the SZ or 
SZP grouped scored closely enough to either the PTSD or Control group so that the 
difference was no longer significant. The recognition trial on the explicit verbal memory 
test was not significantly different between any of the groups. The SZP group was not 
significantly different fiom the control or PTSD groups on the visual memory recognition 
trial. Other times when the SZP group was not significantly different fiom the PTSD 
group, were on the Backward Spatial Span test in the Working Memory domain and on
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the percent perseverative errors on the WCST. The Control group was not significantly 
different from the SZ group on the FAS total or on the Trail Making Test part A. Some 
possible explanations will be made regarding these differences in the following sections 
discussing the performance separately for each domain.
In addition to the hypothesis that the SZ and SZP groups would demonstrate 
differences on all o f the domains, it was hypothesized that the SZP group would exhibit 
the highest level of impairment based on both the additive and the synergistic models. 
Consistent with the hypothesis, the SZ and SZP groups differed from the PTSD and 
Control groups across all domains, with a few minor exceptions for particular measures 
as discussed above. However, contrary to the hypothesis, the SZP and SZ groups did not 
differ significantly from one another in neurocognitive performance. The only consistent 
pattern was that the SZP group scored slightly higher than the SZ group on all of the 
neurocognitive domains, with the exception of the Attention domain.
The SZP group performed one standard deviation higher than the SZ group on the 
Visual/Learning and Memory domain. This is in sharp contrast to the performance of the 
PTSD group relative to their comparative group, who performed more poorly than the 
Controls. Similarly, the SZP group scored slightly higher than the SZ group on the 
Executive Function domain. Once again, this is an area in which the PTSD performance 
was slightly lower than the Controls. Finally, the last notable comparison between the 
SZP and SZ group was on the Attention domain, representing an interaction effect 
between the groups. On the Attention domain, the SZP group performed more poorly 
than the SZ group. It is unclear as to what these slight differences in performance 
between the SZ and SZP group mean. It would seem that the issue warrants some further
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investigation. It may be that individuals with schizophrenia who have particularly poor 
attentional abilities are more prone to develop PTSD when exposed to trauma, or 
alternatively that trauma and its associated neuropathophysiology expresses itself 
uniquely as an impairment in attention. Performance on the Attention domain was in the 
predicted direction with the SZP group performing more poorly than the SZ group. 
Somewhat surprisingly the SZP group performed relatively better than the SZ group on 
Executive Function and Visual Learning/Memory and not consistent with the pattern of 
performance on these domains in the PTSD group. The comparisons would seem to 
suggest that the PTSD influences performance differently in individuals with and without 
comorbid schizophrenia. At least, in this sample o f individuals with comorbid 
schizophrenia and PTSD, the presence o f PTSD did not negatively influence the 
neurocognitive performance associated with SZ in most domains. When solely 
comparing the mean scores, PTSD even appeared to have a mitigating effect on 
neurocognitive tests, with the exception of the Attention domain. Because the presence 
of comorbid PTSD did not produce a consistent pattern of more severe neurocognitive 
impairment, neither the additive or synergistic model was supported.
The same comparisons for performance o f the groups across neurocognitive 
domains were then conducted using two different covariate analyses. The effects of age 
and education were examined in the first model and the effects o f symptoms measures, in 
particular the scores on the SANS, SAPS and PCL, was examined in the second model. 
The following section, will describe the significant results o f these MANCOVA’s. On 
the Verbal Memory Domain, the SANS was a significant predictor. Univariate analyses 
indicated that the SANS significantly influenced the trials 1-5 scores, the short delay trial
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and the long delay trial. On the MANCOVA, for the Working Memory domain, 
covariate analyses indicated that education was a significant covariate and that it exerted 
effects on the backward sections o f the both the Digit Span and the Spatial Span. 
Covariate analyses utilizing the symptom measures were significant for negative 
symptoms, in particular on the Spatial Span Forward. On the Executive Function 
domain, the only significant predictor was the SANS, although the effect of group was 
still significant. Univariate analyses indicated that the SANS significantly influenced 
Trails B scores and the COW AT Animals named. On the Attention Domain using age 
and education as covariates, the effect for group remained significant, but age was a 
significant predictor and education was marginally significant (p = .06). Both variables 
contributed to performance on the Trail Making Test. Negative symptoms were 
significant, with univariate analyses indicating that negative symptoms significantly 
influence Stroop scores. Overall results o f MANCOVA’s demonstrated that negative 
symptoms exerted the greatest influence on neurocognitive performance.
Hypothesis Four
As predicted in this hypothesis, the presence o f PTSD did not influence 
performance on the WAIS subscales. The PTSD and Control group performed similarly 
and the SZ and SZP groups performed similarly. In evaluating the impact o f age, 
education, and symptom ratings, education was the only variable to significantly impact 
one o f the subtests. Education had a significant influence on the Block Design subtest, 
which is consistent with a large number o f studies indicating that education is 
significantly predictive o f performance on tests of intelligence.
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The data for all of the domains including motor function and the WAIS subtests 
were converted to z-scores to make overall comparisons between the groups. Figure 4 
depicts the performance of each group for all eight domains. As discussed in each of the 
separate domains, the PTSD and Control group scored similarly. In comparing the two 
groups across domains, the largest differences were on the Visual Learning/Memory 
domain, followed by the Executive Function and Working Memory domains, with the 
PTSD group scoring lower than the Control group. These results should be interpreted 
cautiously because the majority of the comparisons made in this study were not 
statistically significant.
Strengths o f  the Study
This investigation makes an important contribution to the literature in that it is 
among the first to examine neurocognitive performance in individuals with comorbid 
schizophrenia and PTSD. Furthermore, this study utilized a comprehensive battery of 
neuropsychological tests to assess all areas of function which have been implicated in the 
pathophysiology of either schizophrenia or PTSD. Also, comprehensive assessment of 
symptoms were conducted and rigorous diagnostic evaluations were implemented will all 
participants. Another strength of this study is that it’s four group design included 
appropriate control groups for the samples affected by PTSD (both a normal control 
group and a schizophrenia control group), which allowed for specific comparisons of 
neurocognitive performance associated with the comorbid group and with each disorder 
singly.
When considering all of the neurocognitive abilities assessed, comorbid PTSD 
exerted its greatest influence on the Attention, Executive Function and Visual
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Learning/Memory domains. While the differences between the SZ and SZP groups were 
not significant, a number of interesting patterns emerged. First, the comorhid group had 
poorer performance on the Attention domain, but scored higher on the Executive 
Function and Visual Learning/Memory domain. While not significant, the difference 
between the SZ and SZP groups averages approximately one standard deviation, so it is 
likely that these differences would become significant with more participants. For the 
PTSD only group, the potential impairment of Visual Learning/Memory was also a 
relatively new finding that has not been explored extensively in the literature.
Another important contribution o f the study is the examination of psychiatric 
symptoms among the three clinical groups. The presence o f comorbid PTSD 
significantly impacted psychiatric symptoms. The SZP group had higher levels of 
positive symptoms (hallucinations, delusions), a finding consistent with the literature 
(Ross, Anderson & Clark, 1994; Beck & van der Kolk, 1987; Craine et al., 1988). This 
study may be the first to also determine that the presence of comorbid PTSD is associated 
with fewer negative symptoms. The SZP group also had the highest scores on the BPRS, 
another more general measure of psychiatric distress. Additionally, as might be expected 
the SZP received higher scores on the measure of PTSD symptoms. The SZP group also 
received higher scores on the PTSD measure than the PTSD only group. Finally, the 
pattern o f performance was the same on a measure of depressive symptoms with the SZP 
group scoring the highest, followed by the PTSD group. Increased levels of depression 
have also been documented in individuals with comorbid schizophrenia and may be 
associated with increased suicidality. These findings certainly have implication for 
treatment, and future studies may further elaborate on the current findings by examining
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the impact of comorbid PTSD in response to various behavioral and pharmacological 
interventions.
Limitations
Several limitations were identified in the current investigation. The number of 
individuals in each of the groups was small, ranging from 21 to 26, contributing to 
potentially decreased statistical power to detect differences among the groups. Other 
studies to evaluate comorbid schizophrenia and PTSD have used comparable sample 
sizes, although some have used larger samples (Scheller-Gilkey et ah, 2004). However, it 
is important to note that many of these studies have not examined patients who carried 
diagnoses of PTSD, but rather made dichotomies between those who had experienced a 
traumatic event at some point in their lives, and those who had not. It is apparent that 
meaningful differences do exist between those who develop PTSD after experiencing 
trauma, and those who do not. So, while limited by a small number o f cases in each 
group, the current study provides valuable information on the effects of PTSD in 
schizophrenia. Also, despite the limited sample size, significant differences were found 
in the current study among the groups on several neurocognitive measures. Future 
studies, however, should attempt to include larger sample sizes to optimize the findings 
and inferences.
The selection process in itself may have posed a threat to internal validity, 
particularly with regard to the PTSD sample. The individuals in the two schizophrenia 
groups and the controls were recruited from Mojave Mental Health and the community, 
whereas the PTSD group was composed primarily of undergraduate psychology students 
from the University of Nevada, Las Vegas. In general, the PTSD participants were high
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functioning, with only mild to moderate PTSD. There is likely to have been a selection 
bias in the PTSD individuals who chose to participate. Studies investigating PTSD have 
documented that individuals who chose to participate in research are usually farther along 
in the recovery process and are potentially using the study as a way to help others 
(Newman & Kaloupek, 2004). In light of the relatively high functioning sample of 
individuals with PTSD, significant differences between the PTSD and Control group may 
not have been detected. Similarly, the heterogeneity of trauma type may have 
contributed to fewer neurocognitive deficits, in that specific types of trauma (e.g., rape) 
are more likely to cause neurocognitive deficits. The differences between the PTSD and 
Control group are expected to be even greater when individuals with more severe 
traumatic event types are evaluated.
Similarly, the magnitude of differences may have been minimized because the 
PTSD and SZP groups were composed o f individuals who had either a lifetime diagnosis 
o f PTSD or a current diagnosis of PTSD. It is anticipated that those with a current 
diagnosis would exhibit more severe symptoms, both psychiatric and neurocognitive. In 
order to at least preliminarily investigate this potential explanation, the PTSD and SZP 
groups were broken down into a current PTSD group, a lifetime PTSD group, a current 
SZP group and a lifetime SZP group. The PTSD and SZP groups were compared 
separately using MANOVA’s on the composite scores for the domains. In the PTSD 
only group there were no significant differences across the domains for a lifetime 
diagnosis versus a current diagnosis. It did appear that the results might have been 
significant if  there was a larger sample. The comparison on the domains for the current 
and lifetime diagnosis in the PTSD group suggested that a current diagnosis of PTSD
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impacted performance on all of the domains in a negative manner. The largest 
differences in performance were on the Verbal Learning/Memory domain, the Visual 
Learning/Memory domain. Executive Function, and Attention. When the same analysis 
was run in the SZP group, the current diagnosis of PTSD was associated with increased 
performance on the Executive Function and Motor domain. Performance was decreased 
by the presence o f current PTSD on the Attention domain. These differences were not 
significant. Once again, the sample sizes were small with an « = 75 and an « = 8.
Another consideration in regards to the sample is that both schizophrenia groups 
had high rates o f traumatic events. Individuals could be included in the SZ group if they 
had a prior history o f trauma, but did not ever have significant distress consistent with a 
PTSD diagnosis. A history of trauma was not part o f the exclusionary criteria for the SZ 
group based on the high prevalence rates of traumatic events in those individuals with 
schizophrenia.
Significance o f  the Study/ Conclusions
As mentioned before, this is among the first studies examining neurocognitive 
impairment associated with comorbid schizophrenia and PTSD. Clarification of 
neurocognitive functioning in individuals with comorbid schizophrenia and PTSD is 
increasingly important for both theoretical and practical reasons. From a theoretical 
standpoint, characterizing the unique strengths and deficits of these patients provides 
insight into underlying pathophysiology and gives direction to research investigating 
discrete neurocognitive deficits as potential endophenotypes for psychiatric disorders. 
Since both PTSD and schizophrenia are complex polygenic disorders that exhibit
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imperfect penetrance, neurocognitive abilities have been suggested as endophentypes 
because they are highly heritable.
From a practical standpoint, there is increasing evidence linking neurocognitive 
abilities to functional outcomes in schizophrenia (Green, Kem, and Heaton, 2004). 
Identifying unique neurocognitive deficits will allow for the development o f treatments 
whose aim is to remediate those deficits and thus improve functioning. Furthermore, 
there are few studies which have examined the impact o f PTSD in schizophrenia on 
psychiatric symptoms. Psychiatric symptoms may lead to increased hospitalization, 
substance abuse, and suicidality, and so the characterization provided here lays the 
groundwork for studies with larger samples whose goals are to link specific treatment 
with specific symptoms. Future studies should examine these issues further, to more 
clearly determine the role of specific cognitive impairments on functional outcomes and 
response to treatment.
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Table 1. Demographic characteristics for the Normal Control (C), Post-Traumatic Stress
Disorder (PTSD), Schizophrenia (SZ), and Schizophrenia with PTSD (SZP) groups.
V ariable Group F P Scheffe
f < 0 5C PTSD SZ SZP df=3,8
8
M ean (SD) M ean (SD) M ean (SD) M ean (SD)
Age 36.3 (13.2) 26.6 (13.2) 39 .5 (10 ,4 ) 40.7 (8.6) 6.60 .00 PTSD  < SZ, SZP
Education 13.2(1 .3) 13.1 (1.0) 12.8(1 .5) 12.1 (1.0) 3.15 .03 N one
N (% ) N (% ) Y (2 1 ) P
Ethnicity 28.55 NS
Asian 1 (4) 1(5) 1 (4 ) 1 (5 )
A m erican
A frican 1 (4) 3 (1 4 ) 12 (46) 3 (1 4 )
A m erican
Biracial 3 (12.5) 3 (1 4 ) 1(4) 2 (9.5)
E uropean 16 (66) 10 (48) 11(42) 12 (57)
A m erican
H ispanic 2 (8 ) 1 (5) 1 (4) 1 (5 )
A m erican
N ative 0 (0 ) 2 (1 0 ) 0 (0 ) 1 (5 )
A m erican
Pacific 0 (0 ) 1 (5) 0 (0 ) 0 (0 )
Islander
O ther 1 (4) 0 (0 ) 0 (0 ) 2 (1 0 )
Sex 10.24 .02
M ale 7 7 18 7
Fem ale 17 12 8 14
N ote: C  (n =  24), PTSD  (n =  21), SZ (n = 26), SZP (n =  21).
Table 2. Symptom ratings for the PTSD, SZ, and SZP groups.
Group
Variable
PTSD (P) SZ SZP Ff2. 6^1 P Scheffe
Post-hoc
Mean SD Mean SD Mean SD
SANS
to ta l Score 3.10 4.60 12.27 6.10 9.50 4.69
Affective flattening 0.52 0.81 3,00 1.36 1.85 1.31 24.84 .001 P<SZP<SZ
Alogia 0.14 0.48 1.96 1.51 1.45 1.43 12.64 .001 P<SZP,SZ
Avolition-apathy 0.48 0.87 2.15 1,71 1.85 1.35 9.22 .001 P<SZP,SZ
Anhedonia- 0.52 0.75 2.50 1.48 1.80 1.67 12.33 .001 P<SZP,SZ
asociality
Attention 0.38 0.50 2.70 1.33 2.55 1.05 32.87 .001 P<SZP,SZ
SAPS
Total Score 1.48 2.50 7.81 3.14 8.65 2.30
Hallucinations 0.24 0.63 1.96 1.69 2.95 1.50 20.48 .001 P<SZ,SZP
Delusions 0.14 0.16 2.50 .91 3.70 .80 123.18 .001 P<SZ<SZP
Bizarre behavior 0.48 0.98 1.73 1.12 1.05 1.36 6.94 .01 P < S Z
Thought disorder 0.24 0.54 1.62 1.42 .95 1.15 8.73 .001 P < SZ
CDS 4.10 4.05 1.31 1.67 7.71 7.08 16.76 .001 SZ,P<SZP
BPRS Total 29.00 10.17 40.12 6.54 45.43 16.00 11.69 .001 P<SZ,SZP
PCL 34.10 17.08 6.69 13.05 51.86 20.56 42.85 .001 SZ<P<SZP
Note: BPRS = Brief Psychiatric Rating Scale, SANS = Schedule for the Assessment o f  Negative Symptoms, SAPS 
= Scale for the Assessment o f  Positive Symptoms, POL = Post Traumatic Stress Disorder Checklist, CDS = Calgary 
Depression Scale.
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Table 9. Comparison of the adjusted and unadjusted means for the Motor Domain.
Corrected 
Uncorrected for Age and 
Test Group Mean Education
Finger Tapping
Dominant Hand NC 49.46 6.13 49.65 2.61
PTSD 48.19 14.82 47.10 2.91
SZ 36.81 13.38 3 7 .3 2 2.50
SZP 32.24 14.85 32.48 2.90
Finger Tapping Non-
Dominant Hand NC 44.71 6 .7 8 44.56 2.47
PTSD 46.19 13.48 44.97 2 .7 6
SZ 35.04 11.63 35.49 2.37
SZP 3 0 .8 6 15.06 31.69 2.75
Pegboard Dominant NC 12.96 5.45 12.85 .84
PTSD 13.14 3.97 12.63 .94
SZ 8 .38 2 .8 6 8 .5 6 .80
SZP 9 .8 6 3 .6 2 10.28 .93
Pegboard Non-Dominant NC 12.38 4.99 12.22 .78
PTSD 12.29 5 .89 11.84 .87
SZ 8.23 3.02 8 .3 7 .75
SZP 9.14 3.44 9.60 .87
Pegboard Both NC 19.46 8 .8 6 19.33 1.43
PTSD 20.33 5 .89 19.58 1.43
SZ 11.65 5.24 11.92 1.37
SZP 12.43 7.30 13.00 1.59
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Table 10. Comparison of adjusted and unadjusted means on the Working Memory
Domain.
Test Group
Uncorrected
Mean
Corrected 
for Age and 
Education
Corrected 
For SANS 
Symptom Rating
Digit Span Forward NC 10.67 1.81 10.57 .45
PTSD 10.52 2.52 10.42 .50 10.50 .61
SZ 7.85 2.19 7.86 .43 7.83 .50
SZP 7.85 2.21 8.12 .50 7.85 .52
Digit Span Backward NC 7.04 1.65 6.89 .33
PTSD 6.52 1.60 6.36 .37 6.12 .44
SZ 4.42 1.84 4.44 .32 4.55 .36
SZP 4.10 1.65 4.42 .37 4.13 .38
Spatial Span Forward NC 8.75 2.03 8.68 .42
PTSD 8.19 1.75 7.92 .47 7.32 .51
SZ 6.27 2.49 6.36 .40 6.80 .42
SZP 5.65 1.76 5.92 .47 5.75 .44
Spatial Span Backward NC 7.54 2.29 7.39 .44
PTSD 7.14 2.54 6.68 .49 6.77 .59
SZ 4.46 2.25 4.60 .42 4.67 .47
SZP 5.25 1.78 5.75 .49 5.29 .50
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Table 11. Comparison of adjusted and unadjusted means for the Verbal Learning and
Memory Domain.
Test Group
Uncorrected
Mean
Corrected 
for Age and 
Education
Corrected 
For SANS
CVLT Trial 1-5 NC 55.25 9.06 54.81 2.35
PTSD 54.24 9.58 53.60 2.63 49.63 3.08
SZ 29.77 10.88 29.89 2.26 32.25 2.49
SZP 33.19 15.36 34.18 2.62 33.08 2.62
CVLT Distractor List NC 7.25 1.92 7.15 .41
PTSD 7.67 2.03 7.35 .45 7.56 .54
SZ 3.92 1.65 4.02 .39 4.03 .44
SZP 4.10 2.45 4.40 .45 3.97 .46
CVLT Short Delay NC 11.21 2.95 11.11 .71
PTSD 11.62 2.91 11.39 .79 10.26 .91
SZ 5.50 3.52 5.56 .68 6.24 .73
SZP 6.71 4.17 6.98 .79 6.69 .77
CVLT Long Delay NC 11.67 2.76 11.54 .69
PTSD 11.86 2.37 11.78 .77 10.50 .88
SZ 5.12 3.53 5.11 .66 5.87 .71
SZP 6.24 4.38 6.47 .77 6.10 .75
CVLT Recognition NC 15.29 1.85 15.10 1.10
PTSD 14.81 1.86 14.24 1.22 15.01 1.65
SZ 16.73 6.64 16.90 1.05 16.49 1.33
SZP 15.76 7.91 16.35 1.22 15.60 1.41
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Table 12. Comparison of adjusted and unadjusted means for Visual Learning and
Memory Domain.
Test Group
Uncorrected
Mean
Corrected 
for Age and 
Education
Biber Trial 1-5 NC 140.43 40.08 138.24 8.56
PTSD 137.05 48.80 132.02 9.80
SZ 60.27 40.63 61.92 8.02
SZP 70.21 32.09 77.06 9.54
Biber Distractor List NC 13.04 7.18 12.88 1.10
PTSD 12.16 5.64 11.42 1.26
SZ 4.08 4.39 4.36 1.03
SZP 4.53 2.39 5.13 1.22
Biber Short Delay NC 34.26 8.32 33.40 2.11
PTSD 31.00 11.16 29.21 2.41
SZ 14.27 11.34 14.84 1.98
SZP 16.11 9.80 18.61 2.35
Biber Long Delay NC 35.39 7.17 34.66 2.00
PTSD 32.95 11.00 31.65 2.29
SZ 14.77 10.42 15.16 1.88
SZP 17.47 9.79 19.37 2.23
Biber Recognition NC 14.57 .73 14.30 .62
PTSD 13.79 3.49 13.59 .71
SZ 10.92 4.05 10.94 .58
SZP 10.92 4.05 13.03 .69
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Table 13. Comparison of adjusted and unadjusted means for Emotional Learning and 
Memory.
Test Group
Uncorrected
Mean
Corrected 
for Age and 
Education
EVLT Trial 1-5 NC 4 8 .6 7 8.01 48 .35 2.35
PTSD 4 5 .3 8 14.60 43.55 2.62
SZ 24 .6 2 10.26 27.10 2 .25
SZP 28 .6 7 12.98 30.07 2.61
EVLT Distractor List NC 5.79 1.64 5.70 .31
PTSD 5.48 1.33 5 .26 .34
SZ 2 .92 1.63 2 .98 .29
SZP 3.19 1.40 3.44 .34
EVLT Short Delay NC 9.46 2 .73 9.28 .62
PTSD 9 .62 3.07 9 .32 .69
SZ 4 .5 8 2.83 4.64 .59
SZP 4.81 3.49 5.24 .69
EVLT Long Delay N C 9.2 9 2 .68 9.09 .63
PTSD 9.38 3.49 9.04 .70
SZ 3.73 3.12 3 .8 0 .60
SZP 4.00 3.10 4.49 .70
EVLT Recognition NC 14.50 1.98 14.31 .63
PTSD 14.29 2.12 14:10 .71
SZ 10.97 3.26 10.98 ,61
SZP 10,71 4.46 11.10 .70
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Table 14. Comparison of adjusted and unadjusted means for Executive Function Domain.
Corrected Corrected
Uncorrected for Age and For Psychiatric
Test Group Mean Education Symptoms (SANS)
WCST % perseverative
errors NC 10.92 5.63 11.14 3.63
PTSD 17.24 15.01 20.51 4.05 19.27 5.61
SZ 33.62 22.09 32.36 3.49 32 .87 4.53
SZP 27.05 24.29 24.46 4.04 26.91 4 .78
WCST categories
completed NC 5.29 1.57 5.28 .40
PTSD 4.62 1.80 4.36 .45 4.46 .56
SZ 1.88 2.03 1.99 .39 1.93 .45
SZP 3.20 2.4 3 .48 .45 3.21 .48
Trails B NC 65.71 19.11 65.42 13.65
PTSD 62.52 20.24 69.37 15.24 83.55 19.82
SZ 183.88 85.93 181.01 13.10 170.56 16.00
SZP 179.15 97.18 171.96 15.19 176.56 16.87
CO WAT FAS NC 37.75 9.53 36.95 2 .24
PTSD 39.10 10.15 3 8 .00 2.50 36,34 2,91
SZ 2 8 .92 12.77 29.11 2.15 30.32 2.35
SZP 26.60 9.53 29.83 2.49 26 .8 7 2 .48
c o w  AT Animals NC 19.88 4.10 19.66 .90
PTSD 20.43 3.43 19.76 1.00 18.78 1.08
SZ 13.62 5.11 13.82 .86 14.59 .88
SZP 13.80 4.00 15.04 1.00 13.99 .92
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Table 15. Comparison of adjusted and unadjusted means for Attention Domain.
Corrected
Corrected For
Uncorrected for Age and Psychiatric
Test Group Mean Education Symptoms
Stroop NC 79.29 1.43 79.17 1.15
PTSD 78.57 3.22 78.35 1.29 77.93 1.71
SZ 76.65 4.40 76.71 1.10 77.10 1.38
SZP 73.15 10.06 73.46 1.32 72.88 1.49
Trails A NC 33.08 11.41 34.60 3.85
PTSD 28.57 7.18 33.30 4.31 35.87 5.52
SZ 56.12 30.28 54.73 3.69 51.07 4.46
SZP 46.85 19.40 41.86 4.40 47.29 4.83
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Table 16. Comparison of adjusted and unadjusted means for the WAIS subscales.
Test Group
Uncorrected
Mean
Corrected 
for Age and 
Education
Vocabulary NC 42.35 12.02 41.52 2.40
PTSD 36.90 8.63 36.71 2.71
SZ 26.38 12.72 26.23 2.25
SZP 25.62 12.16 26.92 2.62
Information NC 16.00 4.84 15.65 .95
PTSD 15.50 4.17 15.51 1.04
SZ 11.08 4.67 11.09 .89
SZP 10.57 4.58 11.20 1.04
Block Design NC 37.43 9.52 36.88 2.20
PTSD 37.75 14.51 36.07 2.39
SZ 23.50 9.19 24.32 2.06
SZP 23.33 9.42 25.10 2.40
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Demographic Questionnaire
Please answer the following questions completely and honestly. A ll o f  your responses will remain 
confidential.
1. Birth Date ________ /_
Month
2. Gender Male Female
3. Ethnicity/Race; 
Native
Day Year
Asian American
. African American 
. Hispanic/Latino 
Other
4. Highest Level of Education Completed
5. Marital Status; ________ Married
________ Remarried
American Indian/Alaska
Hawaiian/Pacific Islander 
Biracial
(Years)
Widowed
Separated
(Months)
Divorced 
Never married
6. Usual or last Occupation
7. Usual living arrangements (past 3 yr.):
_______ With partner and children
_______ With children alone
________With family
_______ Alone
_______ No stable arrangements
With partner alone 
With parents 
, With friends 
Controlled environment 
Other ______________
8. How many children do you have? ______________________
9. Have you ever been homeless? Yes No
10. Do you have a twin? Yes No
11. Are you left handed, right handed, or ambidextrous? Left Right Ambidextrous
HEALTH-RELATED QUESTIONS
12. Are you color-blind? Yes No
13. Do you have diabetes? Yes No
14. Is your vision corrected (glasses/contacts)? Yes No 
Are you wearing them now? Yes No
15. Do you have severe visual impairments, such as cataracts or glaucoma? Yes No
161
16. Do you have any hearing loss (hearing aid)? Yes No
17. Have you ever or do you now have seizures? Yes No
18. Have you ever had a head injury (e.g., automobile accident, fall, sports injury)? Yes No
19. Have you ever been unconscious? Yes No If so, for how long?______________
20. Do you have any medical conditions? Yes No {please describe)
21. Do you have any neurological disorders? Yes No
22. Do you have a learning disability? Yes No
Has this been formally diagnosed? Yes No Diagnosis:
23. Have you ever received ECT treatment? Yes No
24. Have you ever received psychosurgery? Yes No
25. Do you smoke? Yes No
a. Cigarettes? Yes No
b. Cigars / Pipes? Yes No
c. Chewing tobacco? Yes No
d. How many per day? _______________________
26. When you were born:
a. Were you born full term? Yes No Don’t Know
I. If premature, how many months was the pregnancy?
b. Were there any obstetric complications? Yes No Don’t Know
c. Was your mother exposed to anything during her pregnancy (e.g., disease, 
toxins, alcohol, etc.)? Yes No Don’t Know
d. Was your birth normal (e.g., head first, natural birth)? Yes No Don’t Know
e. Did your mother smoke when she was pregnant? Yes No Don’t Know
FAMILY HISTORY QUESTIONS
Please com plete these questions concerning you r family. P lease D O  N O T  list any specific names or 
identify any specific person  in your answers.
27. Does anyone in your family have a mental disorder? Yes No
28. Do you have any first degree relatives (e.g., mother, father, brother, child) with a mental 
disorder? Yes No
a. What is the disorder?
i. Schizophrenia Yes No
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a.
ii. Affective disorder Yes No
iii. Alcoholism Yes No
iv. Parkinsonism Yes No
V. Movement disorder Yes No
vi. Schizophrenia spectrum disorder Yes No
vii. Other
lave any second degree relatives (e.g., aunt, uncle, grandmottier, grandfattier) with a
isorder? Yes No
What is the disorder?
i. Schizophrenia Yes No
ii. Affective disorder Yes No
iii. Alcoholism Yes No
iv. Parkinsonism Yes No
V. Movememt disorder Yes No
vi. Schizophrenia spectrum disorder Yes No
vii. Other
30. Please list any medications you are currently taking
Current Medications Dosage Date Started
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